{
  "meta": {
    "title": "00400_Late_Night_Pyq_Pyt_Pharma-2",
    "url": "https://brainandscalpel.vercel.app/00400-late-night-pyq-pyt-pharma-2-cb444ce0.html",
    "scrapedAt": "2025-11-29T17:29:42.555Z"
  },
  "questions": [
    {
      "id": 23234,
      "choices": [
        {
          "id": 92900,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 92901,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 92902,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 92903,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are the components of Nada's Minor Criteria? (INICET MAY 2023)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Systolic mumur Grade 3</span></li><li><span style=\"font-size:12.0pt;\">Diastolic murmur</span></li><li><span style=\"font-size:12.0pt;\">Abnormal second heart sound</span></li><li><span style=\"font-size:12.0pt;\">Abnormal BP</span></li></ol>",
      "unique_key": "Q2099172",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683591,
      "difficulty_level": "intermediate",
      "subjects_id": [
        13
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nada’s criteria is used for detection of CHD on the basis of clinical evaluation.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/18/screenshot-2024-09-18-151020.png\" alt=\"\" width=\"1000\" height=\"287\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Presence of 1 major or 2 minor criteria suggest presence of heart disease.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\">In Nada’s criteria for detecting congenital heart disease, minor criteria include an abnormal second heart sound and abnormal blood pressure. The presence of one major or two minor criteria suggests the presence of heart disease.</span></p>",
      "correct_choice_id": 92900,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6534,
      "choices": [
        {
          "id": 26105,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 26106,
          "text": "<p><span style=\"font-size:12.0pt;\">Donepezil</span></p>"
        },
        {
          "id": 26107,
          "text": "<p><span style=\"font-size:12.0pt;\">Selegiline</span></p>"
        },
        {
          "id": 26108,
          "text": "<p><span style=\"font-size:12.0pt;\">Haloperidol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An elderly man presents with rigidity and tremors. On examination, he has blank facial expressions. Which of the following drugs can be used to manage this condition? (NEET PG 2022)</span></p>",
      "unique_key": "Q7492175",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683562,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Selegiline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's symptoms of rigidity, tremors, and blank facial expressions are suggestive of Parkinson's disease, a neurodegenerative disorder characterized by the loss of dopaminergic neurons in the substantia nigra. Selegiline is a monoamine oxidase B (MAO-B) inhibitor that is used in the management of Parkinson's disease. It works by inhibiting the breakdown of dopamine, thereby increasing its availability in the brain and helping to alleviate symptoms like rigidity and tremors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Clozapine</strong>: Clozapine is an atypical antipsychotic primarily used in the treatment of schizophrenia. While it can be used in Parkinson's disease patients who experience psychosis, it is not a first-line treatment for the primary motor symptoms of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Donepezil</strong>: Donepezil is an acetylcholinesterase inhibitor used in the treatment of Alzheimer’s disease. It enhances cholinergic function by increasing the concentration of acetylcholine in the brain. It is not typically used for treating Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Haloperidol</strong>: Haloperidol is a typical antipsychotic and can actually worsen Parkinson's disease symptoms. It blocks dopamine receptors, which could exacerbate the dopamine deficiency characteristic of Parkinson's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Selegiline is a monoamine oxidase B (MAO-B) inhibitor that increases dopamine availability in the brain and is used to manage the motor symptoms of Parkinson's disease, such as rigidity and tremors.</span></p>",
      "correct_choice_id": 26107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6477,
      "choices": [
        {
          "id": 25877,
          "text": "<p><span style=\"font-size:12.0pt;\">Duration of action is longer than filgrastim</span></p>"
        },
        {
          "id": 25878,
          "text": "<p><span style=\"font-size:12.0pt;\">Added advantage is that it can be taken orally</span></p>"
        },
        {
          "id": 25879,
          "text": "<p><span style=\"font-size:12.0pt;\">It is contraindicated in patients with sickle cell anemia</span></p>"
        },
        {
          "id": 25880,
          "text": "<p><span style=\"font-size:12.0pt;\">It is not effective in the treatment of severe neutropenia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true about pegylated-filgrastim? (NEET PG 2019)</span></p>",
      "unique_key": "Q5433803",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683596,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Duration of action is longer than filgrastim</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Pegylated-filgrastim, also known as peg-filgrastim, is a long-acting formulation of filgrastim that is used to stimulate the production of white blood cells in patients receiving chemotherapy. The addition of polyethylene glycol (PEG) to filgrastim increases its molecular weight and slows down its clearance from the body, resulting in a longer duration of action compared to normal filgrastim.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Added advantage is that it can be taken orally:&nbsp;</strong> Pegylated-filgrastim cannot be taken orally, as it is administered by injection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is contraindicated in patients with sickle cell anemia:</strong> Pegylated-filgrastim is not contraindicated in sickle cell patients, but caution should be exercised as it can stimulate the production of white blood cells, increasing the risk of sickling crises.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is not effective in the treatment of severe neutropenia:</strong> Pegylated-filgrastim is effective in the treatment of severe neutropenia and can help to reduce the risk of infection in patients undergoing chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Pegylated-filgrastim has a longer duration of action than regular filgrastim due to its pegylation, which slows its clearance from the body. It is effective in the treatment of severe neutropenia and is administered by injection, not orally. While not contraindicated in sickle cell anemia, caution is advised due to the potential risk of stimulating white blood cell production and increasing the risk of sickling crises.</span></p>",
      "correct_choice_id": 25877,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64667,
      "choices": [
        {
          "id": 257861,
          "text": "<p><span style=\"font-size:16px;\">Extrapulmonary TB like Tubercular meningitis</span></p>"
        },
        {
          "id": 257862,
          "text": "<p><span style=\"font-size:16px;\">Rifampicin resistance with both KatG and inhA mutation</span></p>"
        },
        {
          "id": 257863,
          "text": "<p><span style=\"font-size:16px;\">Rifampicin-sensitive TB</span></p>"
        },
        {
          "id": 257864,
          "text": "<p><span style=\"font-size:16px;\">Rifampicin-resistant but fluoroquinolone-sensitive TB</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is an inclusion criterion for the shorter bedaquiline regimen in the treatment of tuberculosis? (Twisted PYQ)</span></p>",
      "unique_key": "Q2241863",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683570,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. D) Rifampicin-resistant but fluoroquinolone-sensitive TB</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">The shorter bedaquiline regimen is specifically designed for treating certain cases of drug-resistant tuberculosis. It is typically indicated in cases of <strong>Rifampicin-resistant (RR) tuberculosis</strong> or <strong>multidrug-resistant (MDR) tuberculosis</strong> under certain conditions. This regimen is used when the tuberculosis strain is resistant to Rifampicin, but it remains sensitive to fluoroquinolones.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Additionally, in cases where there is resistance to Isoniazid (INH), the shorter regimen can be used if the resistance is due to a mutation in either the KatG or inhA gene, but not both.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">If both mutations are present, or if the TB is severe or extrapulmonary, the shorter regimen is not recommended.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option A. Extrapulmonary TB like Tubercular meningitis:&nbsp;</strong>The shorter bedaquiline regimen is not indicated for extrapulmonary TB, as it is intended for pulmonary TB only. Extrapulmonary TB often requires a longer and more complex treatment regimen.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option B. Rifampicin resistance with both KatG and inhA mutation:&nbsp;</strong>This scenario represents a more complex form of MDR-TB where resistance occurs due to mutations in both the KatG and inhA genes. The presence of both mutations generally excludes the use of the shorter regimen, as a longer and more intensive treatment is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Option C. Rifampicin-sensitive TB:&nbsp;</strong>The shorter bedaquiline regimen is not indicated for Rifampicin-sensitive TB. This regimen is specifically designed for drug-resistant cases, particularly those resistant to Rifampicin.</span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:16px;\">Bedaquiline shorter regimen is indicated for the treatment of -</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:16px;\">Rifampicin-resistant TB (FQ sensitive) or MDR TB</span></li><li><span style=\"font-size:16px;\">INH Resistant TB – due to mutation in either inhA or Kat G gene (NOT BOTH)</span></li><li><span style=\"font-size:16px;\">Pulmonary TB</span></li></ul>",
      "correct_choice_id": 257864,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33868,
      "choices": [
        {
          "id": 135310,
          "text": "<p><span style=\"font-size:12.0pt;\">70 percent of the drug undergoes first pass metabolism in liver.</span></p>"
        },
        {
          "id": 135311,
          "text": "<p><span style=\"font-size:12.0pt;\">The drug is 30 percent pure in its chemical composition.</span></p>"
        },
        {
          "id": 135312,
          "text": "<p><span style=\"font-size:12.0pt;\">The drug is 30 percent potent in producing therapeutic effect.</span></p>"
        },
        {
          "id": 135313,
          "text": "<p><span style=\"font-size:12.0pt;\">30 percent of the drug reaches the systemic circulation in unchanged form</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">What does it mean when a drug has a bioavailability of 30 percent? (Fmge Jan 2024)</span></p>",
      "unique_key": "Q4813404",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683595,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Ans D. 30 percent of the drug reaches the systemic circulation in unchanged form</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">This statement accurately defines bioavailability. Bioavailability is the percentage of an administered drug dose that reaches the systemic circulation without being metabolized or changed. In this case, a bioavailability of 30 percent means that only 30 percent of the drug dose reaches the systemic circulation, while the rest may be eliminated or metabolized before reaching the bloodstream.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option A.</strong> <strong>70 percent of the drug undergoes first-pass metabolism in the liver:</strong> This statement is not a direct explanation of bioavailability but is related to the fate of the drug after absorption. If 30 percent is bioavailability, then 70 percent of drug is either not absorbed or undergo first pass metabolism. First-pass metabolism in the liver can reduce the amount of drug available for systemic circulation, but it doesn't define bioavailability.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12pt;\"><strong>Option B.</strong> <strong>The drug is 30 percent pure in its chemical composition:</strong> This statement is incorrect. Bioavailability is not related to the purity of a drug but rather to its absorption and availability in the bloodstream.</span></p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>The drug is 30 percent potent in producing a therapeutic effect:</strong> This statement is not an accurate description of bioavailability. Potency refers to the strength or concentration of a drug required to produce a specific effect, while bioavailability is about how much of the administered dose reaches the systemic circulation.</span></p>",
      "correct_choice_id": 135313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6526,
      "choices": [
        {
          "id": 26073,
          "text": "<p><span style=\"font-size:12.0pt;\">Digoxin Immune Fab</span></p>"
        },
        {
          "id": 26074,
          "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine</span></p>"
        },
        {
          "id": 26075,
          "text": "<p><span style=\"font-size:12.0pt;\">DC cardioversion</span></p>"
        },
        {
          "id": 26076,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenytoin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was brought to the emergency room after consuming 8 digoxin tablets. On examination, he was found to be unstable, with a heart rate of 56 beats per minute. An ECG revealed a third-degree heart block. What is the next step in this patient's care? (NEET PG 2022)</span></p>",
      "unique_key": "Q3783201",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683619,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Digoxin Immune Fab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For the management of Digoxin toxicity having the features of Bradycardia and a 3<sup>rd</sup> degree heart block, we need to administer Digibind, which is an antibody against Digoxin. It is also known as Digoxin immune Fab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lidocaine:&nbsp;</strong>Lidocaine<strong> </strong>is used to treat Ventricular Tachycardia or Ventricular Fibrillation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. DC cardioversion:&nbsp;</strong>DC cardioversion is used for tachyarrhythmias when pharmacologic treatment fails. It is not used in bradyarrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phenytoin:&nbsp;</strong>Phenytoin is an antiepileptic used for the treatment of GTCS. It can also be used as a class Ib antiarrhythmic drug for the treatment of Digoxin induced Ventricular Tachycardia, or any polymorphic ventricular tachycardia due to QT prolongation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The administration of Digoxin Immune Fab is the next step in the management of life-threatening digoxin toxicity, particularly in the presence of bradycardia and third-degree heart block.</span></p>",
      "correct_choice_id": 26073,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33870,
      "choices": [
        {
          "id": 135318,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Rifampicin</span></span></p>"
        },
        {
          "id": 135319,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Isoniazid</span></span></p>"
        },
        {
          "id": 135320,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ethambutol</span></span></p>"
        },
        {
          "id": 135321,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyrazinamide</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anti-tubercular drugs cause visual problems as an adverse effect?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Fmge Jan 2024)</span></span></p>",
      "unique_key": "Q8463608",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683597,
      "difficulty_level": "beginner",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Ethambutol</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethambutol is the anti-tubercular drug that can cause visual problems as an adverse effect. It is known for its potential to lead to optic neuritis, which can result in changes in visual acuity and color vision. Monitoring of vision is important during the use of ethambutol, and if visual disturbances occur, the drug may need to be discontinued to prevent further optic nerve damage.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> <strong>Rifampicin:</strong> Rifampicin is not typically associated with visual problems as an adverse effect.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B.</strong> <strong>Isoniazid:</strong> Isoniazid is not known to cause visual problems. However, it is associated with hepatotoxicity and peripheral neuropathy as potential adverse effects.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Pyrazinamide:</strong> Pyrazinamide is not commonly associated with visual problems as an adverse effect.</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective: </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ethambutol is the anti-tubercular drug known for its association with visual problems. It can cause optic neuritis and changes in color vision, which may be reversible upon discontinuation of the drug.</span></span></p>",
      "correct_choice_id": 135320,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64668,
      "choices": [
        {
          "id": 257865,
          "text": "<p><span style=\"font-size:12.0pt;\">Tenofovir</span></p>"
        },
        {
          "id": 257866,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
        },
        {
          "id": 257867,
          "text": "<p><span style=\"font-size:12.0pt;\">Dolutegravir</span></p>"
        },
        {
          "id": 257868,
          "text": "<p><span style=\"font-size:12.0pt;\">Emtricitabine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs lacks significant activity against hepatitis B but is commonly used for HIV treatment? (Twisted PYQ)</span></p>",
      "unique_key": "Q3043594",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683571,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Dolutegravir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Dolutegravir is an integrase strand transfer inhibitor (INSTI) used as a key component in HIV treatment regimens. However, it does not exhibit significant activity against hepatitis B virus (HBV). Unlike tenofovir, lamivudine, or emtricitabine, which are active against both HIV and HBV, dolutegravir specifically targets HIV by preventing integration of viral DNA into the host genome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Tenofovir</strong> – Tenofovir has potent activity against both HIV and HBV, making it a dual-use medication.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Lamivudine</strong> – Lamivudine is effective against both HIV and HBV, often included in regimens for co-infected individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Emtricitabine</strong> – Similar to lamivudine, emtricitabine has dual activity against both HIV and HBV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Drugs like tenofovir, lamivudine, and emtricitabine have dual activity against HIV and HBV, making them critical for treating co-infections. In contrast, dolutegravir is specific to HIV and lacks significant efficacy against HBV, demonstrating the importance of selecting appropriate medications based on infection type.</span></p>",
      "correct_choice_id": 257867,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44864,
      "choices": [
        {
          "id": 179103,
          "text": "<p>RANK ligand inhibitor</p>"
        },
        {
          "id": 179104,
          "text": "<p>NMDA antagonist</p>"
        },
        {
          "id": 179105,
          "text": "<p>NK1 receptor antagonist</p>"
        },
        {
          "id": 179106,
          "text": "<p>5HT3 antagonist</p>"
        }
      ],
      "text": "<p>What is the mechanism of action of Aprepitant? (NEET PG 2017)</p>",
      "unique_key": "Q1099068",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683589,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><strong>Correct Answer: C. NK1 receptor antagonist</strong></p><p>&nbsp;</p><p><strong>Explanation:</strong>&nbsp;</p><p>&nbsp;</p><p>Aprepitant is a selective, high-affinity NK1 receptor antagonist that blocks the emetic action of substance P. It works by specifically binding to neurokinin-1 receptors in the central nervous system, particularly in the chemoreceptor trigger zone (CTZ) and nucleus tractus solitarius (NTS). This mechanism is distinct from the more common 5-HT3 receptor antagonists used as antiemetics.</p><p>&nbsp;</p><p><strong>Other Options:</strong></p><p>&nbsp;</p><ul><li><strong>Option A. RANK ligand inhibitor</strong> - This mechanism belongs to drugs affecting bone metabolism like denosumab, not to antiemetic medications.</li><li><strong>Option B. NMDA antagonist</strong> - This mechanism relates to certain anesthetics and analgesics, not to aprepitant or other antiemetics.</li><li><strong>Option D. 5-HT3 antagonist</strong> - While this is the mechanism for ondansetron, granisetron, and palonosetron, aprepitant specifically works through NK1 receptors with minimal effect on 5-HT3 receptors.</li></ul><p>&nbsp;</p><p><strong>Educational Objective:</strong>&nbsp;</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Aprepitant's unique NK1 receptor antagonism makes it particularly valuable for preventing delayed chemotherapy-induced nausea and vomiting when combined with 5-HT3 antagonists and dexamethasone, providing superior control over the complete course of CINV.</span></p>",
      "correct_choice_id": 179105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64669,
      "choices": [
        {
          "id": 257869,
          "text": "<p><span style=\"font-size:12.0pt;\">Telmisartan</span></p>"
        },
        {
          "id": 257870,
          "text": "<p><span style=\"font-size:12.0pt;\">Irbesartan</span></p>"
        },
        {
          "id": 257871,
          "text": "<p><span style=\"font-size:12.0pt;\">Olmesartan</span></p>"
        },
        {
          "id": 257872,
          "text": "<p><span style=\"font-size:12.0pt;\">Losartan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following ARBs is safe in both severe renal and hepatic impairment without requiring dose adjustment? (Twisted PYQ)</span></p>",
      "unique_key": "Q6326832",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683572,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Olmesartan</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Olmesartan, along with eprosartan, is unique among Angiotensin Receptor Blockers (ARBs) in that it does not require dose adjustment in patients with either renal or hepatic impairment, making it safe for use in such conditions. This is due to its minimal dependence on renal or hepatic clearance pathways compared to other ARBs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Telmisartan</strong> – Telmisartan requires dose adjustment in hepatic impairment due to its biliary excretion and is avoided in severe renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Irbesartan</strong> – Irbesartan is contraindicated in severe renal and hepatic failure, as it relies on both pathways for metabolism and clearance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Losartan</strong> – While losartan has additional thromboxane A2 receptor antagonism and antiplatelet effects, it requires dose adjustment in hepatic impairment and should be avoided in severe renal disease due to the risk of hyperkalemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Among ARBs, <strong>olmesartan and eprosartan</strong> stand out for their safety in both severe renal and hepatic impairment without requiring dose adjustment. Understanding these exceptions is critical for optimizing treatment in patients with comorbidities.</span></p>",
      "correct_choice_id": 257871,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44826,
      "choices": [
        {
          "id": 178951,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin</span></span></span></p>"
        },
        {
          "id": 178952,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride</span></span></span></p>"
        },
        {
          "id": 178953,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></p>"
        },
        {
          "id": 178954,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 30-year-old patient presents with progressive dyspnoea at rest and on exertion (e.g., climbing stairs). The patient also has a history of heart failure. Laboratory tests show a fasting plasma glucose of 136 mg/dL, haemoglobin (Hb) of 13 g%, and HbA1c of 7.8%, indicating poorly controlled type 2 diabetes mellitus. The physician needs to select an appropriate antidiabetic medication considering the patient&#39;s symptoms and medical condition. Which is the preferred antidiabetic drug in this patient?</span></span></span>(INICET MAY 2024)</p>",
      "unique_key": "Q7453314",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683569,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Dapagliflozin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dapagliflozin is an SGLT2 inhibitor that promotes glucose excretion through the urine. It has been shown to provide significant benefits in patients with type 2 diabetes and heart failure, including reducing the risk of hospitalization for heart failure and cardiovascular death. Given the patient&#39;s history of heart failure, dapagliflozin is a preferred choice due to its cardiovascular benefits.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>B.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Glimepiride</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Glimepiride is a sulfonylurea that increases insulin secretion. It is associated with a risk of hypoglycemia and weight gain, which might not be ideal for this patient considering the need to manage cardiovascular risk factors and avoid potential hypoglycemic episodes.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>C.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Metformin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin is a first-line treatment for type 2 diabetes due to its efficacy and safety profile. However, in this case, given the patient&#39;s history of heart failure, dapagliflozin may provide additional cardiovascular benefits that make it a more suitable choice.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option&nbsp;</span></strong><span style=\"font-family:Calibri,sans-serif\"><strong>D.</strong>&nbsp;</span><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Sitagliptin</strong>:&nbsp;</span></span></span><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin is a DPP-4 inhibitor that helps improve blood glucose control with a low risk of hypoglycemia and is weight neutral. While it is effective, it does not have the same cardiovascular benefits as dapagliflozin in patients with heart failure.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In summary, dapagliflozin is the preferred antidiabetic drug for this patient due to its proven benefits in reducing heart failure-related outcomes, making it particularly suitable for a patient with a history of heart failure and poorly controlled diabetes.</span></span></p>",
      "correct_choice_id": 178951,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6485,
      "choices": [
        {
          "id": 25909,
          "text": "<p><span style=\"font-size:12.0pt;\">Leflunomide</span></p>"
        },
        {
          "id": 25910,
          "text": "<p><span style=\"font-size:12.0pt;\">Chloroquine</span></p>"
        },
        {
          "id": 25911,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 25912,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfasalazine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old female patient with a history of rheumatoid arthritis has been experiencing visual changes, including blurry vision and halos around lights. She has been on medication for her rheumatoid arthritis for a couple of years now. Which of the following drugs she might be taking is known to get deposited in the cornea? (NEET PG 2020)</span></p>",
      "unique_key": "Q6499287",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683601,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chloroquine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chloroquine, an antimalarial drug also used in rheumatoid arthritis, can get deposited in various ocular tissues, including the cornea and retina. Corneal deposits are usually reversible upon discontinuation of the drug but can lead to visual disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Leflunomide:</strong> Leflunomide is an immunomodulatory drug used in rheumatoid arthritis but is not known for deposition in the cornea. It has a different side effect profile mainly affecting the liver and gastrointestinal system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Methotrexate:</strong> Methotrexate is a commonly used drug for rheumatoid arthritis but does not get deposited in the cornea. It has its own set of side effects like bone marrow suppression, liver toxicity, and gastrointestinal disturbances.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sulfasalazine:</strong> Sulfasalazine is also used for rheumatoid arthritis but is not known to deposit in the cornea. Its main side effects include gastrointestinal symptoms, skin rash, and rarely, hematologic abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chloroquine, used in the treatment of rheumatoid arthritis, can get deposited in the cornea, leading to visual disturbances such as blurry vision and halos around lights. This side effect is an important consideration in the long-term management of patients on chloroquine therapy.</span></p>",
      "correct_choice_id": 25910,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44819,
      "choices": [
        {
          "id": 178923,
          "text": "<p><span style=\"font-size:12pt;\">Conjugated estrogen</span></p>"
        },
        {
          "id": 178924,
          "text": "<p><span style=\"font-size:12pt;\">Estrone</span></p>"
        },
        {
          "id": 178925,
          "text": "<p><span style=\"font-size:12pt;\">Estradiol</span></p>"
        },
        {
          "id": 178926,
          "text": "<p><span style=\"font-size:12pt;\">Estriol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Most potent natural estrogen is (INICET MAY 2024)</span></p>",
      "unique_key": "Q6840690",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683567,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Estradiol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Estradiol (E2) is the most potent natural estrogen. It is the primary estrogen produced by the ovaries during the reproductive years and plays a crucial role in regulating the menstrual cycle and reproductive system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;A.</strong>&nbsp;<strong>Conjugated estrogen</strong>: Conjugated estrogen like Ethinyl estradiol is a synthetic estrogen commonly used in oral contraceptives. It is not a natural estrogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;B.</strong>&nbsp;<strong>Estrone</strong>: Estrone (E1) is one of the three naturally occurring estrogens. It is less potent than estradiol. Estrone is primarily produced in adipose tissue and is the predominant estrogen after menopause.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option&nbsp;D.</strong>&nbsp;<strong>Estriol</strong>: Estriol (E3) is the weakest of the three natural estrogens. It is primarily produced during pregnancy by the placenta. Estriol has much lower estrogenic activity compared to estradiol and estrone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In summary, estradiol is the most potent natural estrogen and plays a significant role in the female reproductive system during the reproductive years.</span></p>",
      "correct_choice_id": 178925,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6517,
      "choices": [
        {
          "id": 26037,
          "text": "<p><span style=\"font-size:12.0pt;\">Naproxen</span></p>"
        },
        {
          "id": 26038,
          "text": "<p><span style=\"font-size:12.0pt;\">Indomethacin</span></p>"
        },
        {
          "id": 26039,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 26040,
          "text": "<p><span style=\"font-size:12.0pt;\">Acetaminophen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with chronic kidney disease underwent nephrectomy. Which of the following can be administered as a postoperative analgesic in this patient? (NEET PG 2021)</span></p>",
      "unique_key": "Q3841196",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683612,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Acetaminophen</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with chronic kidney disease (CKD), nonsteroidal anti-inflammatory drugs (NSAIDs) like naproxen, indomethacin, and diclofenac are generally avoided due to their potential to worsen renal function. These medications inhibit prostaglandin synthesis, which can lead to renal vasoconstriction and further decline in kidney function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen (paracetamol), on the other hand, is generally considered safer for patients with CKD when used at appropriate doses. It has a different mechanism of action (inhibit COX3) and does not significantly affect renal hemodynamics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Naproxen: </strong>Naproxen is an NSAID that can significantly impair renal function, especially in patients with pre-existing kidney disease. It should be avoided in this population due to the risk of worsening kidney function and potential for causing renal failure.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Indomethacin: </strong>Indomethacin is another NSAID with similar risks to naproxen. Its use can lead to decreased renal perfusion and exacerbate renal impairment, making it unsuitable for patients with CKD.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Diclofenac: </strong>Diclofenac, like other NSAIDs, poses a significant risk to kidney function in patients with CKD. It can reduce prostaglandin synthesis, leading to renal vasoconstriction and further renal impairment, and should be avoided.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acetaminophen is the preferred postoperative analgesic for patients with chronic kidney disease, as it does not significantly affect renal function and is safer than NSAIDs in this population.</span></p>",
      "correct_choice_id": 26040,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6484,
      "choices": [
        {
          "id": 25905,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythromycin</span></p>"
        },
        {
          "id": 25906,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefotaxime</span></p>"
        },
        {
          "id": 25907,
          "text": "<p><span style=\"font-size:12.0pt;\">Cotrimoxazole</span></p>"
        },
        {
          "id": 25908,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old female patient with a history of chronic obstructive pulmonary disease (COPD) has been taking theophylline for bronchodilation. She now presents with a respiratory infection, and the physician is considering antibiotic therapy. Which of the following antibiotics should not be prescribed with theophylline? (NEET PG 2020)</span></p>",
      "unique_key": "Q4059398",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683600,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Erythromycin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythromycin is known to inhibit the metabolism of theophylline, resulting in elevated blood levels of theophylline. This increases the risk of theophylline toxicity, which can lead to symptoms like nausea, vomiting, seizures, and even cardiac arrhythmias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cefotaxime:</strong> Cefotaxime is a cephalosporin antibiotic and is generally not known to interact significantly with theophylline. It is a safer choice compared to erythromycin in patients on theophylline therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cotrimoxazole:</strong> Cotrimoxazole is a combination of trimethoprim and sulfamethoxazole and is not known to have a significant interaction with theophylline. It can be used safely in patients taking theophylline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amoxicillin:</strong> Amoxicillin is a penicillin antibiotic and does not have significant interactions with theophylline. It can be safely co-prescribed with theophylline.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Erythromycin should not be prescribed with theophylline because it inhibits the metabolism of theophylline, leading to elevated blood levels and an increased risk of toxicity.</span></p>",
      "correct_choice_id": 25905,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6522,
      "choices": [
        {
          "id": 26057,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin</span></span></span></p>"
        },
        {
          "id": 26058,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Heparin</span></span></span></p>"
        },
        {
          "id": 26059,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Dabigatran</span></span></span></p>"
        },
        {
          "id": 26060,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿﻿Rivaroxaban</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with deep vein thrombosis was started on a new drug. After 2 days, he presented with the given finding. Which of the following drugs is implicated in causing the below condition?</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> (NEET PG 2022)</span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/04/2.jpg\" style=\"height:198px; width:200px\" /></span></span></p>",
      "unique_key": "Q5920531",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683616,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Warfarin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The figure shows clinical picture of dermal vascular necrosis, also known as &lsquo;purple toe syndrome&rsquo;. It is an early adverse effect of warfarin. It is seen in patients with genetic protein C deficiency.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dermal Vascular Necrosis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin-induced dermal vascular necrosis is a rare complication of warfarin therapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It characterized by the development of painful skin lesions in patients taking warfarin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is thought to be caused by a transient hypercoagulable state resulting from a rapid reduction in protein C levels in patients with underlying protein C deficiency or other risk factors. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The lesions typically occur in areas with a high concentration of adipose tissue, such as the breasts, thighs, and buttocks.</span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The initial symptoms include red or purple spots on the skin that can quickly progress to painful, necrotic lesions with a central blister or eschar. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The diagnosis is usually made clinically based on the characteristic appearance of the lesions and the patient&#39;s history of warfarin therapy. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of dermal vascular necrosis involves stopping warfarin and initiating alternative anticoagulant therapy, such as heparin or low molecular weight heparin. </span></span></span></li>\r\n\t<li style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In severe cases, surgical intervention may be necessary to remove the necrotic tissue and prevent further damage.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Heparin:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Heparin is an anticoagulant that works by activating antithrombin III, which in turn inhibits thrombin and factor Xa. It does not cause dermal vascular necrosis. However, heparin can cause other complications such as heparin-induced thrombocytopenia (HIT).</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Dabigatran:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dabigatran is a direct thrombin inhibitor used as an anticoagulant. It does not cause dermal vascular necrosis and is generally associated with a different profile of side effects, including bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Rivaroxaban:&nbsp;</span></strong></span></span><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rivaroxaban is a direct factor Xa inhibitor used for anticoagulation. It does not cause dermal vascular necrosis and is associated with a different side effect profile, mainly related to bleeding.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Warfarin can cause dermal vascular necrosis, particularly in patients with protein C deficiency, presenting as painful, necrotic skin lesions shortly after initiation of therapy.</span></span></span></p>",
      "correct_choice_id": 26057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11805,
      "choices": [
        {
          "id": 47186,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Iloprost</span></span></p>"
        },
        {
          "id": 47187,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ambrisentan</span></span></p>"
        },
        {
          "id": 47188,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Nifedipine</span></span></p>"
        },
        {
          "id": 47189,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Epoprostenol</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 35-year-old female patient with class II pulmonary hypertension presents with a negative vasoreactivity test. Which of the following is used in the next step of management? (INICET NOV 2021)</span></span></span></p>",
      "unique_key": "Q4761503",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683573,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Ambrisentan</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pulmonary arterial hypertension (PAH) management depends on the results of the vasoreactivity test. In patients with a negative vasoreactivity test, calcium channel blockers such as nifedipine are not effective. Instead, treatment typically involves the use of endothelin receptor antagonists, phosphodiesterase-5 inhibitors, or prostanoids.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For a patient with WHO functional class II PAH and a negative vasoreactivity test, the next step in management often includes endothelin receptor antagonists like Ambrisentan. Ambrisentan works by blocking the effects of endothelin-1, a potent vasoconstrictor, thereby reducing pulmonary vascular resistance and improving symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Iloprost:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Iloprost is a prostacyclin analog, used primarily in more advanced stages of PAH (class III or IV) or when other treatments have failed. It is not typically the first-line treatment for class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Nifedipine:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Nifedipine, a calcium channel blocker, is used in patients with a positive vasoreactivity test. Since this patient has a negative vasoreactivity test, nifedipine is not appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Epoprostenol:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Epoprostenol is another prostacyclin analog used in advanced PAH (class III or IV) or refractory cases. It is not typically used for initial treatment in class II PAH with a negative vasoreactivity test.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In class II and class III pulmonary arterial hypertension (PAH), the best option is to use a combination of a phosphodiesterase inhibitor like Tadalafil and an endothelin receptor antagonist like Ambrisentan. Combination therapy is preferred, even though it may not be listed in all options. For refractory class III and class IV PAH patients, prostanoids are used.</span></span></span></p>",
      "correct_choice_id": 47187,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24717,
      "choices": [
        {
          "id": 98829,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</span></p>"
        },
        {
          "id": 98830,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial focused solely on the use of pembrolizumab for treating NSCLC.</span></p>"
        },
        {
          "id": 98831,
          "text": "<p><span style=\"font-size:12.0pt;\">The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC.</span></p>"
        },
        {
          "id": 98832,
          "text": "<p><span style=\"font-size:12.0pt;\">The trial looked at nivolumab as a treatment option for NSCLC.</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An oncologist is discussing with a colleague about the latest evidence-based approaches to treating non-small cell lung cancer (NSCLC). The KEYNOTE-189 trial comes up in their conversation. Which of the following accurately describes the focus of the KEYNOTE-189 trial? (</span>INICET May 2023)</p>",
      "unique_key": "Q6873833",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683565,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. The trial investigated NSCLC treatment using a combination of pembrolizumab and chemotherapy.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The KEYNOTE trials are a series of clinical studies investigating the use of pembrolizumab, an immune checkpoint inhibitor, in various types of cancer. Pembrolizumab targets the PD-1 receptor, thereby enabling the immune system to better recognize and attack cancer cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. The trial focused solely on the use of pembrolizumab for treating NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial investigated pembrolizumab in combination with chemotherapy, not as a monotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. The study explored the efficacy of combining nivolumab and chemotherapy for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial did not involve nivolumab; it focused on pembrolizumab in combination with chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. The trial looked at nivolumab as a treatment option for NSCLC</strong>: This is incorrect. The KEYNOTE-189 trial was centered on pembrolizumab, not nivolumab.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/02/screenshot-2023-12-02-110349.png\" alt=\"\" width=\"1000\" height=\"639\"></span></p>",
      "correct_choice_id": 98829,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44868,
      "choices": [
        {
          "id": 179119,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3 and 4</span></p>"
        },
        {
          "id": 179120,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 2 and 4</span></p>"
        },
        {
          "id": 179121,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4 and 2</span></p>"
        },
        {
          "id": 179122,
          "text": "<p><span style=\"font-size:12pt;\">4, 2, 1 and 3</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">Many GPCR receptors act via increase in cAMP. There are several steps involved in this mechanism as given below. Which of the following is correct sequence of events in cAMP signal transduction pathway? (</span>INICET May 2024)</p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Steps involved</span></p><p><br><span style=\"font-size:12.0pt;\">1. Activation of adenylate cyclase</span><br><span style=\"font-size:12.0pt;\">2. Activation of PKA</span><br><span style=\"font-size:12.0pt;\">3. Conversion of ATP to cAMP</span><br><span style=\"font-size:12.0pt;\">4. Phosphorylation of target proteins</span></p>",
      "unique_key": "Q2011234",
      "question_audio": null,
      "question_video": null,
      "map_id": 33732166,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 1, 3, 2 and 4</strong></span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">The correct sequence of events in the cAMP signal transduction pathway is:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Activation of adenylate cyclase</span></li><li><span style=\"font-size:12pt;\">Conversion of ATP to cAMP</span></li><li><span style=\"font-size:12pt;\">Activation of PKA</span></li><li><span style=\"font-size:12pt;\">Phosphorylation of target proteins</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. 1, 3, 2 and 4</strong></span></p>",
      "correct_choice_id": 179120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6930,
      "choices": [
        {
          "id": 27688,
          "text": "<p><span style=\"font-size:12.0pt;\">Ketoconazole</span></p>"
        },
        {
          "id": 27689,
          "text": "<p><span style=\"font-size:12.0pt;\">Indinavir</span></p>"
        },
        {
          "id": 27690,
          "text": "<p><span style=\"font-size:12.0pt;\">Lamivudine</span></p>"
        },
        {
          "id": 27691,
          "text": "<p><span style=\"font-size:12.0pt;\">Zidovudine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with AIDS was treated with zidovudine, lamivudine, indinavir, ketoconazole and cotrimoxazole. He developed nephrolithiasis, central obesity, hyperlipidemia and insulin resistance. Which of the drugs could have been the cause? (AIIMS NOV 2018)</span></p>",
      "unique_key": "Q8894092",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683566,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Indinavir</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indinavir is a protease inhibitor used in the treatment of HIV/AIDS. It is known for several side effects, which include nephrolithiasis (kidney stones), central obesity, hyperlipidemia, and insulin resistance. These adverse effects are part of the metabolic complications often associated with protease inhibitors.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ketoconazole:&nbsp;</strong>Ketoconazole is an antifungal agent that does not typically cause nephrolithiasis, central obesity, hyperlipidemia, or insulin resistance. Its side effects are more related to hepatotoxicity, adrenal insufficiency, and drug interactions due to CYP3A4 inhibition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Lamivudine:&nbsp;</strong>Lamivudine is a nucleoside reverse transcriptase inhibitor (NRTI) used in the treatment of HIV/AIDS. It is not commonly associated with nephrolithiasis, central obesity, hyperlipidemia, or insulin resistance. Its side effects can include lactic acidosis and hepatic steatosis, but these are less common.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Zidovudine:&nbsp;</strong>Zidovudine, another NRTI, is associated with side effects such as anemia, neutropenia, and myopathy but not with the specific metabolic complications listed (nephrolithiasis, central obesity, hyperlipidemia, insulin resistance).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Indinavir, a protease inhibitor used in HIV/AIDS treatment, is the drug responsible for causing nephrolithiasis, central obesity, hyperlipidemia, and insulin resistance among the medications listed.</span></p>",
      "correct_choice_id": 27689,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 31809,
      "choices": [
        {
          "id": 127106,
          "text": "<p><span style=\"font-size:12pt;\">Cycloserine</span></p>"
        },
        {
          "id": 127107,
          "text": "<p><span style=\"font-size:12pt;\">Ethionamide</span></p>"
        },
        {
          "id": 127108,
          "text": "<p><span style=\"font-size:12pt;\">Streptomycin</span></p>"
        },
        {
          "id": 127109,
          "text": "<p><span style=\"font-size:12pt;\">Pyrazinamide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young patient undergoing treatment for multidrug-resistant tuberculosis (MDR-TB) presents with symptoms of weight gain, cold intolerance, and lethargy. Laboratory investigations reveal high levels of thyroid-stimulating hormone (TSH) and low levels of T3 (triiodothyronine) and T4 (thyroxine). Which of the following drugs is likely responsible for these symptoms? (INICET NOV 2023)</span></p>",
      "unique_key": "Q8481746",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683590,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Ethionamide.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line antitubercular agent used in the treatment of MDR-TB, is known to cause hypothyroidism as a side effect. This condition is characterized by an underactive thyroid gland, leading to symptoms such as weight gain, cold intolerance, and lethargy. The laboratory findings of elevated TSH and low levels of T3 and T4 further support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Cycloserine:</strong> Cycloserine is used in the treatment of MDR-TB, but its side effects are more commonly neurological, including mood changes and seizures. It is not typically associated with thyroid dysfunction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Streptomycin:</strong> Streptomycin, an aminoglycoside antibiotic, is used in TB treatment and is known for its potential ototoxicity and nephrotoxicity, rather than effects on thyroid function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Pyrazinamide:</strong> Pyrazinamide is a first-line anti-TB medication. Its side effects include hepatotoxicity and hyperuricemia but not typically hypothyroidism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Ethionamide, a second-line drug used in the treatment of multidrug-resistant tuberculosis (MDR-TB), can cause hypothyroidism, characterized by symptoms such as weight gain, cold intolerance, lethargy, elevated TSH, and low T3 and T4 levels.</span></p>",
      "correct_choice_id": 127107,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6474,
      "choices": [
        {
          "id": 25865,
          "text": "<p><span style=\"font-size:12.0pt;\">Contraindicated in persons with hyperlipidemia</span></p>"
        },
        {
          "id": 25866,
          "text": "<p><span style=\"font-size:12.0pt;\">It can cause increased sensitivity to sunlight</span></p>"
        },
        {
          "id": 25867,
          "text": "<p><span style=\"font-size:12.0pt;\">Female patients should avoid getting pregnant for 3 years after therapy</span></p>"
        },
        {
          "id": 25868,
          "text": "<p><span style=\"font-size:12.0pt;\">Acitretin has a half-life of about 50 hours</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A dermatologist wants to prescribe acitretin to a patient with psoriasis. Which of the following statements is false regarding the drug? (NEET PG 2019)</span></p>",
      "unique_key": "Q1135562",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683594,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Contraindicated in persons with hyperlipidemia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The false statement regarding acitretin is that it is contra-indicated in persons with hyperlipidemia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Although, acitretin can result in increase in serum LDL-cholesterol and triglycerides and decrease in HDL-cholesterol, this adverse effect is more likely in patients with disturbances of lipid metabolism, diabetes mellitus, obesity, increased alcohol intake, or a familial history of these conditions. Therefore, serum lipids must be more closely monitored in high-risk patients and during long-term treatment. Dietary modifications, reduction in dose, or drug therapy should be employed to control significant elevations of triglycerides. If, despite these measures, hypertriglyceridemia and low HDL levels persist, the discontinuation of acitretin should be considered. So, acitretin is not contra-indicated in these patients, but should be used cautiously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acitretin can cause increased sensitivity to sunlight,</strong> and patients should be advised to use sun protection and avoid excessive sun exposure during therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Female patients should avoid getting pregnant for 3 years after therapy:&nbsp;</strong>Female patients of childbearing age should avoid getting pregnant after therapy because acitretin is teratogenic and can cause fetal malformations. Effective contraception should be used during treatment and for at least 3 years after therapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Acitretin has a half-life of about 50 hours</strong>, which means it can take several weeks for the drug to be eliminated from the body after discontinuing therapy. This long half-life also means that accumulation of the drug can occur with repeated dosing, increasing the risk of toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Acitretin is not contraindicated in persons with hyperlipidemia, although lipid levels should be monitored during therapy. The drug increases sensitivity to sunlight, requires women to avoid pregnancy for 3 years after therapy due to its teratogenicity, and has a long half-life of about 50 hours.</span></p>",
      "correct_choice_id": 25865,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7084,
      "choices": [
        {
          "id": 28304,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 2 represents inverse agonist﻿﻿﻿</span></span></span></span></span></p>"
        },
        {
          "id": 28305,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 3 represents agonist and drug 4 represents inverse agonist</span></span></span></span></span></p>"
        },
        {
          "id": 28306,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 4 represents inverse agonist</span></span></span></span></span></p>"
        },
        {
          "id": 28307,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿Drug 2 represents partial agonist and drug 3 represents inverse agonist</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following statement is correct regarding the given graph?</span></span></span>(INICET May 2022)</p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-4.jpg\" style=\"height:277px; width:300px\" /></span></span></span></span></p>",
      "unique_key": "Q4238162",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683583,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C.&nbsp;</span></span></strong><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug 1 represents agonist and drug 4 represents inverse agonist</span></span></strong></span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 1 = Full agonist, showing the maximal effect, having an intrinsic efficacy of +1</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Salbutamol is a &beta;2 receptor agonist</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 2 = Partial agonist, produces submaximal effect and has an intrinsic efficacy in the range of 0 to +1. E.g., Buprenorphine at the opioid receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 3 = Antagonist, having no effect of its own at the receptor, that is an intrinsic efficacy of 0.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Naltrexone and Naloxone at the opioid receptors.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drug 4 = Inverse agonist, produces opposite effect and has a negative intrinsic efficacy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E.g., Beta-</span><span style=\"font-size:12.0pt\">Carboline is an inverse agonist at benzodiazepine site of GABA-A receptor.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 1</span></strong><span style=\"font-size:12.0pt\">: Shows the highest level of response, indicating it is a full agonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 2</span></strong><span style=\"font-size:12.0pt\">: Shows a submaximal response, indicating it is a partial agonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 3</span></strong><span style=\"font-size:12.0pt\">: Shows no change in response, indicating it is an antagonist.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Drug 4</span></strong><span style=\"font-size:12.0pt\">: Shows a negative response, indicating it is an inverse agonist.</span></span></span></p>",
      "correct_choice_id": 28306,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6499,
      "choices": [
        {
          "id": 25965,
          "text": "<p><span style=\"font-size:12.0pt;\">A</span></p>"
        },
        {
          "id": 25966,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿B</span></p>"
        },
        {
          "id": 25967,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Both A and B</span></p>"
        },
        {
          "id": 25968,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The graph below shows the relationship between the log(dose) and the response of three drugs, A, B, and C. Which of these drugs has the highest potency? (NEET PG 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/neet-pharma-1_VLHh3pD.jpg\" alt=\"\" width=\"300\" height=\"252\"></span></p>",
      "unique_key": "Q7660999",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683606,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The potency of a drug corresponds to the power of the drug. The drug which produces the response at a lower dose is more potent than another drug which produces the same response at a higher dose.</span></li><li><span style=\"font-size:12.0pt;\">The more left the curve is on the DRC, the greater is its potency.</span></li><li><span style=\"font-size:12.0pt;\">On the other hand, efficacy means the maximum response that is produced by a drug. In a DRC, the more the height of the curve, the more efficacious that drug is.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Therefore in this case,</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The potency of Drug A &gt; Drug B &gt; Drug C</span></li><li><span style=\"font-size:12.0pt;\">The Efficacy of Drug A = Drug B &gt; Drug C</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a dose-response curve, the drug with the curve furthest to the left is the most potent because it produces the desired effect at the lowest dose. In this case, Drug A is the most potent.</span></p>",
      "correct_choice_id": 25965,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "ImageBased",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10097,
      "choices": [
        {
          "id": 40354,
          "text": "<p><span style=\"font-size:12.0pt;\">Causes metabolic and enzymatic activity to stop</span></p>"
        },
        {
          "id": 40355,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents the cells from sticking to the slide surface</span></p>"
        },
        {
          "id": 40356,
          "text": "<p><span style=\"font-size:12.0pt;\">Colors the red cells</span></p>"
        },
        {
          "id": 40357,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixes cells to slide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the function of Acetone Free Methanol in Leishman stain? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8953820",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683609,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Causes metabolic and enzymatic activity to stop</strong></span><br><br><span style=\"font-size:12.0pt;\">Acetone-free methanol serves as a fixing agent in the Leishman stain process. Its primary function is to cause metabolic and enzymatic activity to stop, which preserves cellular architecture. This fixation occurs through protein denaturation and halts all biological processes, maintaining the cellular structure for microscopic examination. Therefore, the correct choice would be: \"Causes metabolic and enzymatic activity to stop.\"</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The procedure of Leishman stain:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Freshly prepare and rapidly air-dry blood film.</span></li><li><span style=\"font-size:12.0pt;\">Cover the film with Leishman's Stain (S018S) and allow it to act for 1 minute. Methanol in the stain fixes the preparation.</span></li><li><span style=\"font-size:12.0pt;\">Add double the volume of distilled water to the slide and mix.</span></li><li><span style=\"font-size:12.0pt;\">Allow the diluted stain to act for 10-12 minutes.</span></li><li><span style=\"font-size:12.0pt;\">Wash the film with distilled water or phosphate buffer of pH 7.0, drain and dry in air and examine</span></li></ul><p><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br><br><span style=\"font-size:12.0pt;\"><strong>Option B. Prevents the cells from sticking to the slide surface:</strong> This is incorrect because methanol doesn't prevent adhesion; rather, it preserves cellular structure through protein denaturation.</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Colors the red cells:</strong> This is not the role of acetone-free methanol. The actual coloring of the cells is performed by the dye components in the Leishman stain (methylene blue and eosin).</span><br><br>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fixes cells to slide:</strong> While methanol is a fixative, its primary mechanism is stopping metabolic activity, not adhering cells to the slide. As previously noted, adhesion to the slide surface is the function of substances like albumin.</span><br><span style=\"font-size:12.0pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Acetone-free methanol in the Leishman stain primarily functions by causing metabolic and enzymatic activity to stop through protein denaturation, which preserves cellular architecture and enables proper staining and microscopic&nbsp;examination.</span></p>",
      "correct_choice_id": 40354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "InstrumentsBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6443,
      "choices": [
        {
          "id": 25741,
          "text": "<p><span style=\"font-size:12.0pt;\">Mifepristone</span></p>"
        },
        {
          "id": 25742,
          "text": "<p><span style=\"font-size:12.0pt;\">Flutamide</span></p>"
        },
        {
          "id": 25743,
          "text": "<p><span style=\"font-size:12.0pt;\">Finasteride</span></p>"
        },
        {
          "id": 25744,
          "text": "<p><span style=\"font-size:12.0pt;\">Metyrapone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following inhibits the synthesis of glucocorticoid?(NEET PG 2018)</span></p>",
      "unique_key": "Q7199249",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683581,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Metyrapone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metyrapone is a drug that inhibits the synthesis of glucocorticoids by blocking the enzyme 11β-hydroxylase. This enzyme is crucial for the final step in the biosynthesis of cortisol in the adrenal cortex. By inhibiting this enzyme, metyrapone reduces the production of cortisol and is used in the diagnosis and management of Cushing's syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mifepristone: </strong>Mifepristone is an anti-progestogen and also acts as a glucocorticoid receptor antagonist but does not inhibit the synthesis of glucocorticoids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Flutamide: </strong>Flutamide is an androgen receptor antagonist used primarily in the treatment of prostate cancer. It does not affect glucocorticoid synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Finasteride: </strong>Finasteride is a 5-α reductase inhibitor used in the treatment of benign prostatic hyperplasia (BPH) and androgenic alopecia. It inhibits the conversion of testosterone to dihydrotestosterone (DHT) and has no effect on glucocorticoid synthesis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Mifepristone is an Anti-Progestogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Flutamide is an androgen receptor antagonist.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Finasteride is a 5-α Reductase inhibitor.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metyrapone is enzyme 11ß-hydroxylase inhibitor.</span></p>",
      "correct_choice_id": 25744,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 54891,
      "choices": [
        {
          "id": 219025,
          "text": "<p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma</span></p>"
        },
        {
          "id": 219026,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant glaucoma</span></p>"
        },
        {
          "id": 219027,
          "text": "<p><span style=\"font-size:12.0pt;\">Fuch heterochromic iridocyclitis</span></p>"
        },
        {
          "id": 219028,
          "text": "<p><span style=\"font-size:12.0pt;\">Phacomorphic glaucoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 80 year old male presented with diminution of vision since 2 years. The right eye was red and painful. On examination, the IOP was 50 mmHg in right eye and 16 mmHg in left eye. The right eye had deep anterior chamber with some cells and flare. What could be the possibility? (INICET MAY 2024)</span></p>",
      "unique_key": "Q5457997",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683608,
      "difficulty_level": "beginner",
      "subjects_id": [
        8
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Phacolytic glaucoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma is characterized by the leakage of lens proteins through an intact lens capsule, which causes an inflammatory response in the eye. This condition often occurs in elderly patients with hypermature cataracts. The leakage of proteins results in cells and flare in the anterior chamber, as well as a deep anterior chamber. The clinical presentation described in the question, including the deep anterior chamber with cells and flare and the patient's age, aligns with the characteristics of phacolytic glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Malignant glaucoma</strong>: Malignant glaucoma, also known as aqueous misdirection syndrome, is characterized by a shallow anterior chamber and elevated intraocular pressure (IOP). This condition typically does not present with cells and flare in the anterior chamber, making it an unlikely diagnosis in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fuch heterochromic iridocyclitis</strong>: Fuch heterochromic iridocyclitis usually presents in younger patients, and it is less likely to occur in an 80-year-old individual. This condition is characterized by heterochromia (difference in eye color) and mild anterior uveitis, but it does not typically present with the deep anterior chamber and the level of inflammation described in the question.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Phacomorphic glaucoma</strong>: Phacomorphic glaucoma occurs due to the swelling of a mature cataract, which leads to a shallow anterior chamber and increased IOP. The question describes a deep anterior chamber, which is not consistent with phacomorphic glaucoma.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Phacolytic glaucoma presents with a deep anterior chamber, cells and flare due to leakage of lens proteins, and typically occurs in elderly patients with hypermature cataracts.</span></p>",
      "correct_choice_id": 219025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44862,
      "choices": [
        {
          "id": 179095,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin</span></span></span></p>"
        },
        {
          "id": 179096,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></span></span></p>"
        },
        {
          "id": 179097,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Fondaparinux</span></span></span></p>"
        },
        {
          "id": 179098,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dabigatran</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following anticoagulant requires coagulation profile monitoring? (</span></span></span>INICET May 2024)</p>",
      "unique_key": "Q9926497",
      "question_audio": null,
      "question_video": null,
      "map_id": 33732168,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Lepirudin</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lepirudin</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> is a direct thrombin inhibitor that typically requires regular monitoring of anticoagulant effect via activated partial thromboplastin time (aPTT).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Enoxaparin&nbsp;</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(a low molecular weight heparin), <strong>Fondaparinux</strong> (a synthetic pentasaccharide), and <strong>Dabigatran</strong> (a direct thrombin inhibitor) generally do not require regular monitoring in most patients, although there may be specific clinical situations where monitoring is needed.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 179096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20908,
      "choices": [
        {
          "id": 83596,
          "text": "<p><span style=\"font-size:12.0pt;\">Clotrimazole</span></p>"
        },
        {
          "id": 83597,
          "text": "<p><span style=\"font-size:12.0pt;\">Griseofulvin</span></p>"
        },
        {
          "id": 83598,
          "text": "<p><span style=\"font-size:12.0pt;\">Terbinafine</span></p>"
        },
        {
          "id": 83599,
          "text": "<p><span style=\"font-size:12.0pt;\">Flucytosine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A bronchial asthma patient who is on inhalational steroids presented with white patchy lesions on the tongue and buccal mucosa. What is the drug that can be used to treat this condition?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(NEET PG 2023)</span></p>",
      "unique_key": "Q5226795",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683582,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Clotrimazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given clinical scenario of white patchy lesions on the tongue and buccal mucosa in a patient using inhalational steroids points to diagnosis of oral candidiasis and drug that can be used for the treatment is clotrimazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Asthma patients use MDI which can result in deposition of steroids in the oropharyngeal space, which might lead to cough, dysphonia, and oral candidiasis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is classified under Azole group of Anti-Fungal drugs, acts by inhibiting fungal sterol (ergosterol) synthesis. Used topically in treatment for topical fungal infections like tinea and candida</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/picture1.jpg\" alt=\"\" width=\"700\" height=\"289\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Griseofulvin</strong>: Griseofulvin interferes with microtubule function and disrupts mitosis, disrupting the fungal cell division. It is mainly used against dermatophytes and is the drug of choice for tinea capitis in children. But it is not effective against Candida.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>Terbinafine</strong>: Terbinafine acts by inhibiting the fungal enzyme squalene epoxidase. which reduces ergosterol biosynthesis. Used to treat nail onychomycosis and other dermatophytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Flucytosine</strong></span><span style=\"font-size:12pt;\">: Flucytosine acts by inhibiting nucleic acid synthesis. Used exclusively to combat systemic fungal infections (e.g., cryptococcal meningitis) in combination with amphotericin B.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Clotrimazole is the drug of choice for treating oral candidiasis, especially in patients who develop the condition as a side effect of inhalational steroid use. It works by inhibiting ergosterol synthesis, compromising the fungal cell membrane integrity.</span></p>",
      "correct_choice_id": 83596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20914,
      "choices": [
        {
          "id": 83620,
          "text": "<p><span style=\"font-size:12.0pt;\">Probenecid</span></p>"
        },
        {
          "id": 83621,
          "text": "<p><span style=\"font-size:12.0pt;\">Colchicine</span></p>"
        },
        {
          "id": 83622,
          "text": "<p><span style=\"font-size:12.0pt;\">Diclofenac</span></p>"
        },
        {
          "id": 83623,
          "text": "<p><span style=\"font-size:12.0pt;\">Allopurinol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with recurrent attacks of gout was started on a therapy that inhibits the synthesis of uric acid. His symptoms were relieved after therapy. Identify the drug he was prescribed? (NEET PG 2023)</span></p>",
      "unique_key": "Q5635837",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683585,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Allopurinol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Allopurinol is a competitive inhibitor of the xanthine oxidase enzyme. It decreases the production of uric acid, therefore useful in cases of hyperuricemia and chronic gout.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-171027.png\" alt=\"\" width=\"1000\" height=\"507\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Probenecid</strong>: Probenecid is a uricosuric agent that promotes the excretion of uric acids. Plenty of fluids are given to avoid urate calculi formation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Colchicine</strong></span><span style=\"font-size:12pt;\">: Colchicine is Inhibit granulocyte migration and the release of glycoprotein from neutrophils. Used in Gout, Cirrhosis, Acute Mediterranean Fever, Sarcoidosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Diclofenac</strong></span><span style=\"font-size:12pt;\">: Diclofenac is a Non-Selective COX inhibitor having analgesic, antipyretic, and anti-inflammatory property. A/E – Peptic ulcer disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Allopurinol</strong> is the drug of choice for reducing uric acid synthesis in patients with chronic gout by inhibiting the xanthine oxidase enzyme. It effectively lowers serum and urinary uric acid levels, thereby preventing gout attacks.</span></p>",
      "correct_choice_id": 83623,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6427,
      "choices": [
        {
          "id": 25677,
          "text": "<p><span style=\"font-size:12.0pt;\">Alpha methyldopa</span></p>"
        },
        {
          "id": 25678,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydralazine</span></p>"
        },
        {
          "id": 25679,
          "text": "<p><span style=\"font-size:12.0pt;\">Propranolol</span></p>"
        },
        {
          "id": 25680,
          "text": "<p><span style=\"font-size:12.0pt;\">Labetalol</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antihypertensive are not used in pregnancy?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q3396002",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683574,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Propranolol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Propranolol is a non-selective Beta blocker that is not used in Pregnancy. However, Labetalol is a third generation Beta blocker with additional vasodilatory property which can be used as an antihypertensive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Antihypertensives Safe for Use in Pregnancy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Alpha methyldopa</strong>: This is considered safe for use during pregnancy and is often used as a first-line treatment for hypertension in pregnant women.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hydralazine</strong>: This is also considered safe and is commonly used in managing severe hypertension and hypertensive emergencies during pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Labetalol</strong>: This is a third-generation beta-blocker with additional vasodilatory properties and is considered safe and effective for use in pregnancy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Antihypertensive to be avoided in pregnancy:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">ACE inhibitors, ARBS</span></li><li><span style=\"font-size:12.0pt;\">Diuretics</span></li><li><span style=\"font-size:12.0pt;\">Nonselective beta-blockers</span></li><li><span style=\"font-size:12.0pt;\">Nitroprusside</span></li></ul>",
      "correct_choice_id": 25679,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6468,
      "choices": [
        {
          "id": 25841,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprost</span></p>"
        },
        {
          "id": 25842,
          "text": "<p><span style=\"font-size:12.0pt;\">Dinoprostone</span></p>"
        },
        {
          "id": 25843,
          "text": "<p><span style=\"font-size:12.0pt;\">Misoprostol</span></p>"
        },
        {
          "id": 25844,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboprost</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a synthetic PGE1 derivative used as an abortifacient? (NEET PG 2019)</span></p>",
      "unique_key": "Q6493422",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683592,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Misoprostol</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Misoprostol is a synthetic prostaglandin E1 (PGE1) derivative that is commonly used for inducing labor and as an abortifacient. It is used either alone or in combination with other medications like mifepristone for medical abortion. It can be administered orally, vaginally, or sublingually.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dinoprost</strong>: Dinoprost is a naturally occurring prostaglandin F2-alpha (PGF2α), not a PGE1 derivative. It is also used in obstetrics but is not a synthetic PGE1 derivative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;B. Dinoprostone</strong>: Like Dinoprost, Dinoprostone is another form of prostaglandin but it is a naturally occurring PGE2. It is also used in obstetrics to ripen the cervix and induce labor, but it is not a synthetic PGE1 derivative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option&nbsp;D. Carboprost</strong>: Carboprost is a synthetic analogue of prostaglandin F2-alpha (PGF2α). It is used to induce abortion and treat postpartum hemorrhage but is not a synthetic PGE1 derivative.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the synthetic PGE1 derivative used as an abortifacient is Misoprostol, making option C the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Misoprostol is the synthetic PGE1 derivative used as an abortifacient. It is effective in inducing labor, facilitating medical abortion, and treating postpartum hemorrhage by promoting uterine contractions and cervical ripening.</span></p>",
      "correct_choice_id": 25843,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7026,
      "choices": [
        {
          "id": 28072,
          "text": "<p><span style=\"font-size:14.0pt;\">Aminopenicillins</span></p>"
        },
        {
          "id": 28073,
          "text": "<p><span style=\"font-size:14.0pt;\">Aminoglycosides</span></p>"
        },
        {
          "id": 28074,
          "text": "<p><span style=\"font-size:14.0pt;\">Macrolides</span></p>"
        },
        {
          "id": 28075,
          "text": "<p><span style=\"font-size:14.0pt;\">Carbapenems</span></p>"
        }
      ],
      "text": "<p><span style=\"color:#333333;font-size:12pt;\">Clostridium&nbsp;difficile diarrhoea is most commonly associated with? (AIIMS MAY 2019)</span></p>",
      "unique_key": "Q2421635",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683610,
      "difficulty_level": "difficult",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:14.0pt;\"><strong>Ans.&nbsp;A. Aminopenicillins</strong></span></p><p>&nbsp;</p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:14.0pt;\">Clostridium difficile diarrhea is a super-infection also called as Pseudomembranous colitis.</span></li><li><span style=\"font-size:14.0pt;\">Most common cause is 3rd generation Cephalosporins</span></li><li><span style=\"font-size:14.0pt;\">Other causes include Clindamycin, Aminopenicillins (Ampicillin and&nbsp;Amoxycillin), and Fluoroquinolones.</span></li><li><span style=\"font-size:14.0pt;\">DOC for treatment of PMC is fidaxomicin now.</span></li><li><span style=\"font-size:14.0pt;\">Stool transplant can also be done.</span></li><li><span style=\"font-size:14.0pt;\">Monoclonal antibody against toxin of C.difficile is Bezlotoxumab.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option B. Aminoglycosides:</strong>&nbsp;These can also lead to C. difficile diarrhea, but they are less commonly the cause compared to aminopenicillins and third-generation cephalosporins.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option C. Macrolides:</strong>&nbsp;Macrolides are less likely to cause C. difficile diarrhea compared to aminopenicillins, third-generation cephalosporins, clindamycin, and fluoroquinolones.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Option D. Carbapenems:</strong>&nbsp;Carbapenems are broad-spectrum antibiotics but are not commonly associated with C. difficile diarrhea. Their impact on the gut flora is less significant in this context compared to aminopenicillins and other antibiotics mentioned.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\">Clostridium difficile diarrhea, also known as pseudomembranous colitis, is commonly associated with aminopenicillins such as ampicillin and amoxicillin. Treatment includes fidaxomicin and potentially stool transplants, with bezlotoxumab available as a monoclonal antibody against the toxin of C. difficile.</span></p><p>&nbsp;</p><p><span style=\"font-size:14.0pt;\"><strong>Reference: - KDT 8TH/744</strong></span></p>",
      "correct_choice_id": 28072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5921,
      "choices": [
        {
          "id": 23654,
          "text": "<p><span style=\"font-size:12.0pt;\">Metronidazole</span></p>"
        },
        {
          "id": 23655,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluconazole</span></p>"
        },
        {
          "id": 23656,
          "text": "<p><span style=\"font-size:12.0pt;\">Tetracycline</span></p>"
        },
        {
          "id": 23657,
          "text": "<p><span style=\"font-size:12.0pt;\">Cefixime</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient having frothy vaginal discharge was found to have a strawberry cervix. Which of the following is the drug of choice?&nbsp;</span>(INICET MAY 2021)</p>",
      "unique_key": "Q5912024",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683576,
      "difficulty_level": "beginner",
      "subjects_id": [
        14
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Metronidazole</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The description of a frothy vaginal discharge and a \"strawberry cervix\" is characteristic of <strong>trichomoniasis vaginalis</strong>, a common sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The drug of choice for treating trichomoniasis is <strong>Metronidazole</strong>. This medication can be administered as a single high dose (2g) or in a lower dose (200mg three times daily for 7 days).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fluconazole</strong>: This drug is used for treating candidiasis (yeast infections), not trichomoniasis. Candidiasis typically presents with a curdy white discharge rather than frothy discharge and is not associated with a strawberry cervix.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Tetracycline</strong>: Tetracycline is an antibiotic used for various bacterial infections but is not effective against trichomoniasis. It is not the drug of choice for treating this parasitic infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cefixime</strong>: Cefixime is a cephalosporin antibiotic used to treat bacterial infections like gonorrhea. It is not effective against trichomoniasis and thus is not appropriate for this condition.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/05/screenshot-2024-08-05-164120.png\" alt=\"\" width=\"1000\" height=\"434\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The drug of choice for treating trichomoniasis vaginalis, which presents with frothy vaginal discharge and strawberry cervix, is Metronidazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Page no 554, DC Dutta’s Textbook of gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 23654,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6498,
      "choices": [
        {
          "id": 25961,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenosine antagonism</span></p>"
        },
        {
          "id": 25962,
          "text": "<p><span style=\"font-size:12.0pt;\">PDE 4 inhibition</span></p>"
        },
        {
          "id": 25963,
          "text": "<p><span style=\"font-size:12.0pt;\">Activation of histone deacetylase</span></p>"
        },
        {
          "id": 25964,
          "text": "<p><span style=\"font-size:12.0pt;\">PDE 3 inhibition</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old female with chronic obstructive pulmonary disease (COPD) is receiving theophylline as part of her management plan. She reports increased urination since starting the medication. Theophylline causes diuresis by: (NEET PG 2020)</span></p>",
      "unique_key": "Q9700747",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683605,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Adenosine antagonism.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Theophylline's diuretic effect is primarily due to its antagonism of adenosine receptors, leading to increased renal blood flow and diuresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. PDE 4 inhibition</strong>: Phosphodiesterase (PDE) 4 inhibition by theophylline is more related to its bronchodilatory effects rather than diuresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Activation of histone deacetylase</strong>: This mechanism is thought to contribute to theophylline's anti-inflammatory effects but is not related to diuresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. PDE 3 inhibition</strong>: This is more related to theophylline's cardiac effects rather than diuresis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Adverse Effects of Theophylline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/17/screenshot-2024-07-17-110055.png\" alt=\"\" width=\"1000\" height=\"339\"></strong></span></p>",
      "correct_choice_id": 25961,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "Factual",
        "RecentNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44866,
      "choices": [
        {
          "id": 179111,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Mifepristone</span></p>"
        },
        {
          "id": 179112,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Cabergoline</span></p>"
        },
        {
          "id": 179113,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Chlorpromazine</span></p>"
        },
        {
          "id": 179114,
          "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12pt;\">Metoclopramide</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:4px;text-align:justify;\"><span style=\"font-size:12pt;\">A 30-year-old woman has experienced the loss of her newborn. She is currently producing breast milk, leading to discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. Which of the following drug can be used to prevent this complication? (</span>INICET May 2024)</p>",
      "unique_key": "Q3699515",
      "question_audio": null,
      "question_video": null,
      "map_id": 33732167,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Cabergoline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In this scenario, the goal is to prevent lactation to avoid discomfort and the risk of developing a breast abscess due to milk stasis and incomplete emptying. The appropriate treatment involves using a drug that can suppress prolactin secretion, as prolactin is the hormone responsible for stimulating milk production.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Cabergoline is a dopamine agonist that inhibits prolactin secretion, effectively suppressing lactation. It is often used for this purpose and can be an effective choice in this situation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>A.</strong>&nbsp;<strong>Mifepristone</strong>: Mifepristone is an antiprogestin used for medical termination of pregnancy. It does not have a direct role in suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>C.</strong>&nbsp;<strong>Chlorpromazine</strong>: Chlorpromazine is an antipsychotic medication that can increase prolactin levels, which would not be helpful in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;<strong>D.</strong>&nbsp;<strong>Metoclopramide</strong>: Metoclopramide is a prokinetic agent and antiemetic that also increases prolactin levels, making it unsuitable for suppressing lactation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Given these options, the correct choice for preventing lactation and thus avoiding the associated complications is:&nbsp;<strong>b. Cabergoline</strong></span></p>",
      "correct_choice_id": 179112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7009,
      "choices": [
        {
          "id": 28004,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 28005,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin</span></span></span></p>"
        },
        {
          "id": 28006,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ofloxacin</span></span></span></p>"
        },
        {
          "id": 28007,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythromycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">What is the most bactericidal anti leprotic drug amongst the given drugs? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q5477125",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683604,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Ofloxacin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In general, Rifampicin is the most potent bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">But in cases of Rifampicin resistance, we use regimens consisting of Ofloxacin+ Clofazimine + Clarithromycin/Minocycline are used for 24 months.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Out of these, the fluoroquinolone Ofloxacin is the most bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>A</strong>. <strong>Amoxicillin</strong>: Amoxicillin is a broad-spectrum antibiotic effective against a variety of bacterial infections but is not typically used or effective against Mycobacterium leprae, the bacterium that causes leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ciprofloxacin</span></strong><span style=\"font-size:12.0pt\">: Ciprofloxacin is another fluoroquinolone that has broad antibacterial activity, including some activity against Mycobacterium species. However, it is not as potent as Ofloxacin in the treatment of leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Erythromycin</strong>: Erythromycin is a macrolide antibiotic that has some activity against Mycobacterium species but is less effective and less commonly used in the treatment of leprosy compared to Other Options: like Rifampicin and Ofloxacin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ofloxacin is the most bactericidal anti-leprotic drug among the given options, especially used in cases where there is resistance to the standard first-line treatment with Rifampicin.</span></span></p>",
      "correct_choice_id": 28006,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6904,
      "choices": [
        {
          "id": 27584,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and nor-adrenaline reuptake inhibition</span></p>"
        },
        {
          "id": 27585,
          "text": "<p><span style=\"font-size:12.0pt;\">Anticholinergic</span></p>"
        },
        {
          "id": 27586,
          "text": "<p><span style=\"font-size:12.0pt;\">Antihistaminic</span></p>"
        },
        {
          "id": 27587,
          "text": "<p><span style=\"font-size:12.0pt;\">Serotonin and dopamine reuptake inhibition</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#333333;font-size:12pt;\">Like all the opioids, tramadol acts as an analgesic drug by stimulating mu opioid receptors. Apart from this, the additional analgesic mechanism of tramadol is? (AIIMS NOV 2019)</span></p>",
      "unique_key": "Q8312781",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683615,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"color:#333333;font-size:12pt;\"><strong>Ans. A. Serotonin and nor-adrenaline reuptake inhibition</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tramadol is an atypical opioid analgesic that not only acts by stimulating mu opioid receptors, like other opioids, but also has an additional mechanism of action. This dual mechanism contributes to its analgesic effect.</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12pt;\"><strong>Mu Opioid Receptor Agonism</strong>: Tramadol binds to mu opioid receptors, which are part of the body's endogenous pain relief system. Activation of these receptors leads to pain relief.</span></li><li><span style=\"font-size:12pt;\"><strong>Serotonin and Noradrenaline Reuptake Inhibition</strong>: Unlike typical opioids, tramadol also inhibits the reuptake of serotonin (5-HT) and noradrenaline (NA). This increases the levels of these neurotransmitters in the synaptic cleft, enhancing their action. This mechanism activates the monoaminergic descending inhibitory pathways in the spinal cord, which further contributes to pain relief.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Due to its unique mechanism, tramadol's analgesic action is only partially reversed by naloxone, an opioid antagonist, indicating that non-opioid mechanisms also play a significant role in its pain-relieving effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Anticholinergic:&nbsp;</strong>Tramadol does not have anticholinergic properties. Anticholinergic drugs block the action of acetylcholine in the brain and are not related to the analgesic mechanism of tramadol.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Antihistaminic:&nbsp;</strong>Tramadol does not act as an antihistamine. Antihistamines are used primarily to treat allergic reactions and have no significant role in pain relief through histamine receptor antagonism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Serotonin and dopamine reuptake inhibition:&nbsp;</strong>While tramadol does inhibit serotonin reuptake, it does not inhibit dopamine reuptake significantly. Its main additional mechanism of analgesia is through the inhibition of serotonin and noradrenaline reuptake.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Tramadol provides pain relief not only through mu opioid receptor agonism but also by inhibiting the reuptake of serotonin and noradrenaline, thereby activating the descending inhibitory pain pathways in the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"color:#333333;font-size:12pt;\"><strong>Reference: KDT 8th/504</strong></span></p>",
      "correct_choice_id": 27584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24694,
      "choices": [
        {
          "id": 98737,
          "text": "<p><span style=\"font-size:12.0pt;\">Allen's test</span></p>"
        },
        {
          "id": 98738,
          "text": "<p><span style=\"font-size:12.0pt;\">Adson's test</span></p>"
        },
        {
          "id": 98739,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated arm stress test</span></p>"
        },
        {
          "id": 98740,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicoladoni's test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Before conducting an A-V fistula procedure, which of the following tests is typically conducted? The image of the test is given below: </span><span style=\"font-size:11.0pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2023)</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/surgery-q-bank-1-min.jpg\" alt=\"\" width=\"300\" height=\"379\"></span></p>",
      "unique_key": "Q5643261",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683613,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Allen's test</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given image represents Allen’s test, which indicates the patency of the radial and ulna artery in supplying the hand. Both arteries are compressed alternatively, to check if limb will survive in absence of radial artery (which will be now used in creation of AV fistula).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adson's</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>test</strong>: Adson's test is a provocative test for&nbsp;Thoracic Outlet Syndrome&nbsp;accompanied by compression of the subclavian artery by a cervical rib or tightened anterior and middle scalene muscles. Patient is asked to turn his head to affected side and take a deep breath. Ipsilateral radial pulse will become weak in thoracic outlet syndrome.</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/3.jpg\" alt=\"\" width=\"300\" height=\"252\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Elevated arm</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>stress</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>test</strong>: Elevated arm stress test is a diagnostic tool used in the identification of Thoracic Outlet Syndrome. The patient is asked to abduct his shoulder and flex his forearm and open and close his fists. In presence of thoracic outlet syndrome, the affected limb will get cramps (ischemic) or paresthesia (neurogenic).</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/12/image-3-min.jpg\" alt=\"\" width=\"400\" height=\"265\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nicoladoni's test</strong>: Nicoladoni's test is to be elicited in cases of AV fistula. There is slowing of heart rate in response to manual compression of fistula.</span></p>",
      "correct_choice_id": 98737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ImageBased",
        "INICET",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 43945,
      "choices": [
        {
          "id": 175443,
          "text": "<p><span style=\"font-size:12.0pt;\">Seminoma</span></p>"
        },
        {
          "id": 175444,
          "text": "<p><span style=\"font-size:12.0pt;\">Yolk sac tumor</span></p>"
        },
        {
          "id": 175445,
          "text": "<p><span style=\"font-size:12.0pt;\">Leydig cell tumor</span></p>"
        },
        {
          "id": 175446,
          "text": "<p><span style=\"font-size:12.0pt;\">Sertoli cell tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reinke crystals are seen in which of the following gonadal tumours: (INICET NOV 2023)</span></p>",
      "unique_key": "Q6749667",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683579,
      "difficulty_level": "intermediate",
      "subjects_id": [
        5
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Leydig cell tumor</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Reinke crystals are a specific and distinguishing feature of Leydig cell tumors. These crystals are eosinophilic, rod-shaped, crystalline inclusions found in the cytoplasm of Leydig cells. Leydig cell tumors are non-germ cell, sex cord-stromal tumors of the testicles that are typically benign.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Seminoma:&nbsp;</strong>Does not feature Reinke crystals; characterized by uniform cells with clear cytoplasm and central nuclei, often associated with lymphocytic infiltration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Yolk sac Tumor</strong>: Lacks Reinke crystals; known for Schiller-Duval bodies and a pattern resembling endodermal sinus structures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sertoli cell Tumor</strong>: Also does not contain Reinke crystals; these tumors may show tubular or trabecular growth patterns and are often clinically silent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Reinke crystals are pathognomonic of Leydig cell tumors of the testis and are useful in differentiating these from other testicular neoplasms.</span></p>",
      "correct_choice_id": 175445,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 51445,
      "choices": [
        {
          "id": 205301,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole overdose</span></span></p>"
        },
        {
          "id": 205302,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methanol poisoning</span></span></p>"
        },
        {
          "id": 205303,
          "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Drug interaction</span></span></p>"
        },
        {
          "id": 205304,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Alcohol withdrawal</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old male was on metronidazole therapy for a bacterial infection. He attended a party and consumed alcohol. Shortly after, he developed symptoms including intense facial flushing, severe nausea, vomiting, headache, dizziness, palpitations, and hypotension. What is the likely cause? (FMGE JULY 2024)</span></span></span></p>",
      "unique_key": "Q9487915",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683614,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Drug interaction</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient experienced a <strong>disulfiram-like reaction,</strong> which occurs due to the interaction between metronidazole and alcohol. Metronidazole inhibits the enzyme aldehyde dehydrogenase, which is responsible for metabolizing acetaldehyde, a byproduct of alcohol metabolism. When this enzyme is inhibited, acetaldehyde accumulates in the body, leading to symptoms such as facial flushing, nausea, vomiting, headache, dizziness, palpitations, and hypotension. This reaction is similar to what occurs with the drug disulfiram, which is used to deter alcohol consumption in people with alcohol dependence.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Metronidazole overdose:</span></strong><span style=\"font-size:12.0pt\"> The symptoms described are not indicative of a metronidazole overdose. Overdose of metronidazole may cause different symptoms, including seizures and peripheral neuropathy, rather than the acute symptoms seen in this scenario.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Methanol poisoning:</span></strong><span style=\"font-size:12.0pt\"> Methanol poisoning typically presents with symptoms like ataxia, severe sedation, and visual disturbances, which are not mentioned in this case. Methanol poisoning is also more commonly associated with ingestion of methanol, not the combination of alcohol with metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Alcohol withdrawal:</span></strong><span style=\"font-size:12.0pt\"> Alcohol withdrawal is characterized by symptoms such as tremors, agitation, seizures, and hallucinations, none of which are described in this scenario. Additionally, there is no history of alcohol dependence or cessation in the patient, making withdrawal an unlikely diagnosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metronidazole can cause a disulfiram-like reaction when combined with alcohol, leading to the accumulation of acetaldehyde and subsequent unpleasant symptoms.</span></span></p>",
      "correct_choice_id": 205303,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "FMGE"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6758,
      "choices": [
        {
          "id": 27001,
          "text": "<p><span style=\"font-size:12.0pt;\">Nicorandil</span></p>"
        },
        {
          "id": 27002,
          "text": "<p><span style=\"font-size:12.0pt;\">Molsidomine</span></p>"
        },
        {
          "id": 27003,
          "text": "<p><span style=\"font-size:12.0pt;\">Isosorbide dinitrate</span></p>"
        },
        {
          "id": 27004,
          "text": "<p><span style=\"font-size:12.0pt;\">Nitroglycerin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following drugs causes activation of K<sup>+</sup> channels? (NEET PG 2019)</span></p>",
      "unique_key": "Q9595238",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683607,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nicorandil</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nicorandil is a drug that causes the activation of K<sup>+</sup> channels. It is unique among the options listed because it acts as both a potassium channel opener and has nitrate-like effects, which contribute to its vasodilatory properties. By opening potassium channels, nicorandil causes hyperpolarization of the vascular smooth muscle cells, leading to relaxation and vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Molsidomine: </strong>Molsidomine is a nitric oxide donor that works by activating guanylate cyclase, increasing cyclic GMP (cGMP) levels, and causing vasodilation. It does not activate K<sup>+</sup> channels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Isosorbide dinitrate: </strong>Isosorbide dinitrate is also a nitric oxide donor that acts by increasing cGMP levels through the activation of guanylate cyclase, leading to vasodilation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nitroglycerin: </strong>Nitroglycerin is another nitric oxide donor that causes vasodilation by increasing cGMP levels through the activation of guanylate cyclase.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Nicorandil is the drug that causes activation of K<sup>+</sup> channels, leading to hyperpolarization and vasodilation. It also has nitrate-like effects, distinguishing it from other nitric oxide donors like molsidomine, isosorbide dinitrate, and nitroglycerin, which do not activate K<sup>+</sup> channels but work by increasing cGMP levels.</span></p>",
      "correct_choice_id": 27001,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24710,
      "choices": [
        {
          "id": 98801,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Matzke scale</span></span></span></p>"
        },
        {
          "id": 98802,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Salazar scale</span></span></span></p>"
        },
        {
          "id": 98803,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rummack-mathew</span> <span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">scale</span></span></span></p>"
        },
        {
          "id": 98804,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Krutzko scale</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vancomycin nomogram is known as&nbsp;</span></span></span>(INICET MAY 2023)</p>",
      "unique_key": "Q3706398",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683564,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A. Matzke scale</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The Vancomycin nomogram is also known as the Matzke nomogram or the Matzke scale. It is a tool used to help predict the appropriate dose of vancomycin, an antibiotic, based on the patient&#39;s creatinine clearance and trough serum concentration. The nomogram is a graphical representation that allows healthcare providers to quickly and easily determine the optimal dose of vancomycin for a given patient, taking into account factors such as kidney function and the patient&#39;s weight. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Salazar scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This nomogram is not related to vancomycin dosing. It is used to predict overall survival of patients with cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Rummack-Matthew scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This is used to assess potential hepatotoxicity after acetaminophen intake based on serum acetaminophen concentration.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Krutzko scale</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: There is no widely recognized medical scale or nomogram known as the Krutzko scale.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Vancomycin nomogram, also known as the Matzke scale, is a crucial tool for determining the appropriate dosing of vancomycin based on creatinine clearance and trough serum concentration, ensuring both efficacy and safety in patient treatment.</span></span></span></p>",
      "correct_choice_id": 98801,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6470,
      "choices": [
        {
          "id": 25849,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a GLP- 2 analogue</span></p>"
        },
        {
          "id": 25850,
          "text": "<p><span style=\"font-size:12.0pt;\">Its half-life is 6 - 8 hours</span></p>"
        },
        {
          "id": 25851,
          "text": "<p><span style=\"font-size:12.0pt;\">It is administered orally</span></p>"
        },
        {
          "id": 25852,
          "text": "<p><span style=\"font-size:12.0pt;\">It is recommended for patients with colorectal cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True statement about teduglutide is? (NEET PG 2019)</span></p>",
      "unique_key": "Q3150068",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683593,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) It is a GLP- 2 analogue</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Teduglutide is a glucagon-like peptide-2 (GLP-2) analogue. It is used to treat short bowel syndrome in adults and works by promoting the growth of the intestinal lining, thereby improving nutrient absorption.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Its half-life is 6 - 8 hours</strong>: The half-life of teduglutide is actually around 2 hours, not 6-8 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It is administered orally</strong>: Teduglutide is not administered orally; it is administered via subcutaneous injection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It is recommended for patients with colorectal cancer</strong>: Teduglutide is not recommended for patients with colorectal cancer. It is specifically approved for use in patients with short bowel syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Therefore, the true statement about teduglutide is that it is a GLP-2 analogue, making option A the correct answer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Teduglutide is a GLP-2 analogue used to treat short bowel syndrome. It is administered via subcutaneous injection and has a half-life of about 2 hours. It is not recommended for patients with colorectal cancer.</span></p>",
      "correct_choice_id": 25849,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64670,
      "choices": [
        {
          "id": 257873,
          "text": "<p><span style=\"font-size:12.0pt;\">MDR1</span></p>"
        },
        {
          "id": 257874,
          "text": "<p><span style=\"font-size:12.0pt;\">MRP2</span></p>"
        },
        {
          "id": 257875,
          "text": "<p><span style=\"font-size:12.0pt;\">OATP1B1</span></p>"
        },
        {
          "id": 257876,
          "text": "<p><span style=\"font-size:12.0pt;\">BRCA</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old patient undergoing renal transplant management was started on cyclosporine as part of the immunosuppressive regimen. After a few weeks, the patient begins to show increased plasma levels of cyclosporine and signs of drug toxicity. The treating physician suspects an interaction involving impaired drug uptake into hepatocytes due to the inhibition of a specific transporter. Which transporter is most likely involved in this scenario? (Twisted PYQ)</span></p>",
      "unique_key": "Q5355825",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683575,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) OATP1B1</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">OATP1B1 (Organic Anion Transporting Polypeptide 1B1) is a liver-specific transporter that facilitates the uptake of a wide range of endogenous and exogenous compounds, including cyclosporine, into hepatocytes. Inhibition of OATP1B1 can lead to reduced hepatic uptake of cyclosporine, causing elevated plasma concentrations and increased risk of drug toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: MDR1</strong> – MDR1 (P-glycoprotein) is primarily involved in drug efflux and resistance mechanisms, not uptake. It is not directly responsible for reduced hepatic uptake of cyclosporine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B: MRP2</strong> – MRP2 is an efflux transporter responsible for exporting bile salts and conjugated bilirubin into bile. Its inhibition leads to cholestasis, but it is not involved in the hepatic uptake of cyclosporine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: BRCA</strong> – BRCA genes are involved in DNA repair and are unrelated to drug transport or metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">OATP1B1 is crucial for hepatic drug uptake, and its inhibition can lead to increased plasma drug levels and toxicity. Understanding transporter roles in drug metabolism is essential for managing drug-drug interactions and adverse effects.</span></p>",
      "correct_choice_id": 257875,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 64666,
      "choices": [
        {
          "id": 257857,
          "text": "<p><span style=\"font-size:12.0pt;\">Methotrexate</span></p>"
        },
        {
          "id": 257858,
          "text": "<p><span style=\"font-size:12.0pt;\">Raloxifene</span></p>"
        },
        {
          "id": 257859,
          "text": "<p><span style=\"font-size:12.0pt;\">Tamoxifen</span></p>"
        },
        {
          "id": 257860,
          "text": "<p><span style=\"font-size:12.0pt;\">Anastrozole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the preferred drug for prevention of breast cancer in high-risk post-menopausal women? (Twisted PYQ)</span></p>",
      "unique_key": "Q1172453",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683577,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Raloxifene</strong></span></p><p><br><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Raloxifene is a selective estrogen receptor modulator (SERM) that is FDA-approved for the prevention of breast cancer in high-risk post-menopausal women. It works by blocking the effects of estrogen on breast tissue, thus reducing the risk of developing hormone receptor-positive breast cancer. Unlike tamoxifen, raloxifene is used for prevention rather than active treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Methotrexate</strong> – Methotrexate is a chemotherapy agent used in the treatment of various cancers but has no role in the prevention of breast cancer.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C: Tamoxifen</strong> – While tamoxifen is also used for prevention of breast cancer, it is primarily favored in pre-menopausal women or for treatment in both pre- and post-menopausal women. For post-menopausal women specifically, raloxifene offers a similar preventive benefit with fewer side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Anastrozole</strong> – Anastrozole is used in the <strong>treatment</strong> of hormone receptor-positive breast cancer in post-menopausal women but is not typically used for preventive purposes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Raloxifene is effective in reducing the risk of hormone receptor-positive breast cancer in high-risk post-menopausal women, highlighting its preventive role distinct from the therapeutic roles of tamoxifen or anastrozole. Understanding the differences in use between treatment and prevention is crucial.</span></p>",
      "correct_choice_id": 257858,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20915,
      "choices": [
        {
          "id": 83624,
          "text": "<p><span style=\"font-size:12.0pt;\">Oprelvekin (IL-11)</span></p>"
        },
        {
          "id": 83625,
          "text": "<p><span style=\"font-size:12.0pt;\">Filgrastim</span></p>"
        },
        {
          "id": 83626,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythropoietin</span></p>"
        },
        {
          "id": 83627,
          "text": "<p><span style=\"font-size:12.0pt;\">Amifostine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a malignancy is undergoing chemotherapy. The platelet counts were reduced after the previous cycle of chemotherapy. Which of the following drugs can be used in the treatment of this patient? (NEET PG 2023)</span></p>",
      "unique_key": "Q6301420",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683586,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Oprelvekin (IL-11)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Oprelvekin (IL-11)</strong> is a recombinant form of interleukin-11, which is used to prevent severe thrombocytopenia and reduce the need for platelet transfusions following myelosuppressive chemotherapy in patients with non-myeloid malignancies. Oprelvekin works by stimulating the proliferation and maturation of megakaryocytes, the precursor cells to platelets, thereby increasing platelet counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Filgrastim</strong></span><span style=\"font-size:12pt;\">: Filgrastim is a granulocyte-colony stimulating factor (G-CSF), used in treatment of neutropenia post-chemotherapy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Erythropoietin</strong>: Erythropoietin like Darbepoetin is indicated in Anemia due to chronic kidney disease and bone marrow suppression.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong></span><span style=\"font-size:14.6667px;\"><strong>&nbsp;</strong></span><span style=\"font-size:12.0pt;\"><strong>Amifostine</strong></span><span style=\"font-size:12pt;\">: Amifostine is indicated in cisplatin induced </span><span style=\"font-size:12.0pt;\">nephrotoxicity</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Oprelvekin (IL-11)</strong> is the drug of choice for managing chemotherapy-induced thrombocytopenia by increasing platelet counts, thereby reducing the need for platelet transfusions in patients undergoing myelosuppressive chemotherapy.</span></p>",
      "correct_choice_id": 83624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7164,
      "choices": [
        {
          "id": 28624,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-a, 2-b, 3-c, 4-d</span></span></span></span></span></p>"
        },
        {
          "id": 28625,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-c, 2-d, 3-a, 4-b</span></span></span></span></span></p>"
        },
        {
          "id": 28626,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-d, 2-a, 3-d, 4-c</span></span></span></span></span></p>"
        },
        {
          "id": 28627,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">﻿﻿﻿1-d, 2-c, 3-b, 4-a</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Match the following teratogenic drugs with their teratogenic effects: (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181740.jpg\" style=\"height:290px; width:1000px\" /></span></span></span></p>",
      "unique_key": "Q6711852",
      "question_audio": null,
      "question_video": null,
      "map_id": 33673437,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1-d, 2-c, 3-b, 4-a</span></strong></span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The correctly matched pairs of teratogenic drugs and their effects is 1-d, 2-c, 3-b, 4-a.</span></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lithium is used in the treatment of bipolar disorders and prophylaxis of mania. It is c/I in pregnancy as it leads to Ebstein&rsquo;s anomaly in the fetus, which is characterised by arterialization of the right ventricle and a box shaped heart.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Warfarin leads to defect in the growth of the cartilage (chondrodysplasia punctata) characterized by depressed nasal bridge, stippled epiphyses etc. Warfarin embryopathy is maximally seen when it is used between 6-9 weeks.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thalidomide causes proximal limb defect or Phocomelia. Thalidomide acts via inhibiting angio-genesis, inhibiting cereblon and suppressing immune responses. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloramphenicol inhibits peptidyl transferase. It causes Bone Marrow suppression and leads to grey baby syndrome.</span></span></span></span></span></li>\r\n</ol>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The teratogenic effects of certain drugs is crucial for managing medication use during pregnancy. Lithium can cause Ebstein&rsquo;s anomaly, Warfarin is associated with saddle nose and growth retardation, Thalidomide causes limb malformations, and Chloramphenicol can lead to Grey Baby Syndrome.</span></span></span></p>",
      "correct_choice_id": 28627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6873,
      "choices": [
        {
          "id": 27460,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Baygon</span></span></span></p>"
        },
        {
          "id": 27461,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">TIK 20</span></span></span></p>"
        },
        {
          "id": 27462,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parathion</span></span></span></p>"
        },
        {
          "id": 27463,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endrin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Atropine is indicated in all of the following poisonings except? (AIIMS NOV 2017)</span></span></p>",
      "unique_key": "Q9502634",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683602,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Endrin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine is an anticholinergic agent used to counteract the effects of excessive acetylcholine, such as those seen in organophosphate and carbamate poisoning. It works by blocking the action of acetylcholine on muscarinic receptors, thereby alleviating symptoms of excessive cholinergic activity like salivation, lacrimation, urination, defecation, gastrointestinal distress, and emesis (SLUDGE syndrome).</span></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Endrin is an organochloride pesticide, primarily causing neurotoxic effects, including seizures. The mechanism of toxicity involves disruption of the central nervous system rather than the cholinergic system. Therefore, atropine is not effective in managing Endrin poisoning.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Baygon:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Atropine is indicated as it counters the acetylcholine accumulation due to acetylcholinesterase inhibition caused by organophosphates/carbamates in Baygon.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. TIK 20:&nbsp;</span></strong><span style=\"font-size:12.0pt\">As an organophosphate, TIK 20 poisoning results in excessive acetylcholine, where atropine is beneficial.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathion:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Parathion is an organophosphate pesticide causing acetylcholinesterase inhibition, making atropine an effective treatment.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endrin is an organochloride pesticide. It leads to neurotoxicity, and in that case, Atropine cannot be used in the treatment. Parathion and TIK20 are organophosphates and baygon is a combination of organophosphate and carbamate. For all of these poisonings, atropine is the mainstay of management.</span></span></span></p>",
      "correct_choice_id": 27463,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6932,
      "choices": [
        {
          "id": 27696,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
        },
        {
          "id": 27697,
          "text": "<p><span style=\"font-size:12.0pt;\">Thrombocytopenia</span></p>"
        },
        {
          "id": 27698,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatotoxicity</span></p>"
        },
        {
          "id": 27699,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperammonemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">If carbamazepine is added to ongoing valproate therapy, what adverse effect is risked?</span></p>",
      "unique_key": "Q4983547",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683568,
      "difficulty_level": "intermediate",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Hepatotoxicity</strong></span></p><p>&nbsp;</p><ul><li><span style=\"color:black;font-size:12.0pt;\">Valproate is metabolized by CYP450 enzymes into a minor metabolite, which is hepatotoxic.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Enzyme inducers like carbamazepine phenytoin and Phenobarbital can induce the microsomal enzyme and increase production of this metabolite. This increases the risk of hepatotoxicity.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pancreatitis:&nbsp;</strong>While valproate is associated with a risk of pancreatitis, the addition of carbamazepine does not specifically increase this risk. Pancreatitis is a rare but serious side effect of valproate alone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Thrombocytopenia:&nbsp;</strong>Thrombocytopenia can be a side effect of valproate, but it is not specifically increased by the addition of carbamazepine. Thrombocytopenia results from bone marrow suppression, which is not directly affected by carbamazepine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperammonemia:&nbsp;</strong>Hyperammonemia is a known side effect of valproate and can lead to encephalopathy. However, carbamazepine does not exacerbate this condition.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When carbamazepine is added to ongoing valproate therapy, there is an increased risk of hepatotoxicity due to the induction of cytochrome P450 enzymes by carbamazepine, leading to increased production of a hepatotoxic metabolite of valproate.</span></p>",
      "correct_choice_id": 27698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6428,
      "choices": [
        {
          "id": 25681,
          "text": "<p><span style=\"font-size:12.0pt;\">Iloperidone</span></p>"
        },
        {
          "id": 25682,
          "text": "<p><span style=\"font-size:12.0pt;\">Risperidone</span></p>"
        },
        {
          "id": 25683,
          "text": "<p><span style=\"font-size:12.0pt;\">Clozapine</span></p>"
        },
        {
          "id": 25684,
          "text": "<p><span style=\"font-size:12.0pt;\">Aripiprazole</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following atypical antipsychotics has the highest risk of galactorrhea?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q4324887",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683578,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Risperidone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The antipsychotics work by blocking the D2 receptors in various parts of the brain. The dopaminergic block in the Tuberoinfundibular pathway leads to increase in the levels of Prolactin (As physiologically Dopamine has a negative feedback effect on Prolactin). Typical antipsychotics like Haloperidol have a very high risk of hyperprolactinemia. Among the atypical antipsychotics, Risperidone has the highest risk of galactorrhea.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Iloperidone:&nbsp;</strong>Iloperidone has a lower risk of causing hyperprolactinemia and galactorrhea compared to risperidone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clozapine:&nbsp;</strong>Clozapine has a relatively lower risk of causing hyperprolactinemia and galactorrhea among atypical antipsychotics. It is known for its efficacy in treatment-resistant schizophrenia but has other significant side effects, such as agranulocytosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Aripiprazole:&nbsp;</strong>Aripiprazole is a partial agonist at D2 receptors and is associated with a lower risk of hyperprolactinemia and galactorrhea. In some cases, it can even be used to counteract hyperprolactinemia caused by other antipsychotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism of Hyperprolactinemia</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Dopamine</strong>: Acts as an inhibitory regulator of prolactin secretion via D2 receptors in the tuberoinfundibular pathway.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Antipsychotics</strong>: By blocking D2 receptors, they remove this inhibition, leading to increased prolactin levels.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Prolactin</strong>: Elevated levels can lead to galactorrhea, menstrual disturbances, and sexual dysfunction.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Risperidone is the atypical antipsychotic with the highest risk of causing galactorrhea due to its potent D2 receptor antagonism in the tuberoinfundibular pathway, leading to increased prolactin levels.</span></p>",
      "correct_choice_id": 25682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 44852,
      "choices": [
        {
          "id": 179055,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 179056,
          "text": "<p><span style=\"font-size:12pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 179057,
          "text": "<p><span style=\"font-size:12pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 179058,
          "text": "<p><span style=\"font-size:12pt;\">2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following drug is/are used for cyanide poisoning?</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12pt;\">Amyl nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium nitrite</span></li><li><span style=\"font-size:12pt;\">Sodium thiosulfate</span></li><li><span style=\"font-size:12pt;\">Glyceryl trinitrate</span></li></ol>",
      "unique_key": "Q8757926",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683587,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 1, 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">For cyanide poisoning, the following treatments are commonly used:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1.</strong>&nbsp;<strong>Amyl nitrite</strong>: This is an inhalant that induces methemoglobinemia, which binds cyanide ions and forms cyanmethemoglobin, helping to detoxify cyanide.</span></p><p style=\"margin-left:24px;\">&nbsp;</p><p><span style=\"font-size:12pt;\">2&nbsp;<strong>Sodium nitrite</strong>: This intravenous agent also induces methemoglobinemia, which helps to bind and neutralize cyanide.</span></p><p style=\"margin-left:48px;\">&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3.</strong>&nbsp;<strong>Sodium thiosulfate</strong>: This acts as a sulfur donor, converting cyanide to the less toxic thiocyanate, which is excreted by the kidneys.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4.</strong>&nbsp;<strong>Glyceryl trinitrate</strong> (commonly known as nitroglycerin) is not typically used for cyanide poisoning.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Based on the options provided, the correct combination of drugs used for cyanide poisoning is:&nbsp;<strong>1, 2, and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Therefore, the correct answer is:&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. 1, 2, and 3</strong></span></p>",
      "correct_choice_id": 179057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14133,
      "choices": [
        {
          "id": 56493,
          "text": "<p><span style=\"font-size:12.0pt;\">Posterior urethral valve</span></p>"
        },
        {
          "id": 56494,
          "text": "<p><span style=\"font-size:12.0pt;\">Urethral atresia</span></p>"
        },
        {
          "id": 56495,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior urethral valve</span></p>"
        },
        {
          "id": 56496,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureterocele</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The leading cause of bladder outlet obstruction in male children is: (INICET NOV 2021)</span></p>",
      "unique_key": "Q9201817",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683588,
      "difficulty_level": "beginner",
      "subjects_id": [
        12
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Posterior urethral valve</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This is the most common cause of lower urinary tract obstruction in male infants. PUV is a congenital malformation found only in boys where there is an abnormal fold of tissue in the posterior urethra, preventing normal urine outflow and leading to bladder outlet obstruction. The condition can lead to hydronephrosis if not treated promptly.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Urethral atresia</strong>: This is a rare congenital anomaly where a segment of the urethra fails to canalize or develop. It leads to complete obstruction of the urethra, and while it does cause bladder outlet obstruction, it is less common than PUV in male children.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Anterior urethral valve</strong>: This is a rare congenital anomaly and is much less common than the posterior urethral valve. While it can cause obstruction, its prevalence and significance in causing bladder outlet obstruction in male children are far less than that of PUV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>Ureterocele</strong>: A ureterocele is a cystic dilation of the terminal ureter within the bladder. It can cause obstruction of the ureter itself. They are not the leading cause in male children when compared to PUV.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">The most frequent cause of bladder outflow obstruction in male children is the posterior urethral valve (PUV).</span></li><li><span style=\"font-size:12.0pt;\">PUV is a membranous fold located in the posterior urethra, typically found just distal to the verumontanum. It is thought to occur due to the persistence of the urogenital membrane.</span></li><li><span style=\"font-size:12.0pt;\">Urethral obstruction can cause dilation of the posterior urethral valve, bladder, and bilateral hydronephrosis, leading to a keyhole sign on prenatal ultrasound and potentially oligohydramnios.</span></li><li><span style=\"font-size:12.0pt;\">If not detected prenatally, PUV may present postnatally as a newborn or young infant with urinary tract symptoms, abdominal distension or and recurrent UTIs.</span></li><li><span style=\"font-size:12.0pt;\">Left untreated, PUV may result in chronic kidney disease, bladder dysfunction, and vesicoureteral reflux.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis of PUV is typically based on the presence of an elongated posterior valve during the voiding phase of the voiding cystourethrogram (VCUG).</span></li></ul>",
      "correct_choice_id": 56493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6442,
      "choices": [
        {
          "id": 25737,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin - clavulanic acid</span></p>"
        },
        {
          "id": 25738,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillin</span></p>"
        },
        {
          "id": 25739,
          "text": "<p><span style=\"font-size:12.0pt;\">Piperacillin - tazobactam</span></p>"
        },
        {
          "id": 25740,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following antimicrobials is effective against an organism producing extended-spectrum beta-lactamases?</span> <span style=\"font-size:12.0pt;\">(NEET PG 2018)</span></p>",
      "unique_key": "Q7950024",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683580,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Piperacillin - tazobactam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ESBL is produced by gram-negative organisms like Klebsiella and E. coli. They are resistant to most of the Beta-lactam antibiotics like Penicillin and most of the Cephalosporins. Tazobactam, Sulbactam and Clavulanic acid are beta lactamase inhibitors, hence they can be used against ESBL producing organisms. Therefore, the correct option will be Piperacillin+ Tazobactam combination.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Piperacillin-tazobactam</strong> is effective against ESBL-producing organisms because tazobactam inhibits the beta-lactamase enzyme, allowing piperacillin to exert its antibacterial effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amoxicillin - clavulanic acid: </strong>Although clavulanic acid is a beta-lactamase inhibitor, the combination of amoxicillin and clavulanic acid is generally less effective against ESBL-producing organisms compared to piperacillin-tazobactam.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Penicillin: </strong>Penicillin alone is not effective against ESBL-producing organisms because it is susceptible to degradation by beta-lactamases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ceftriaxone: </strong>Ceftriaxone, a third-generation cephalosporin, is generally ineffective against ESBL-producing organisms as they can hydrolyze this class of antibiotics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Piperacillin-tazobactam is effective against organisms producing extended-spectrum beta-lactamases (ESBLs) due to the beta-lactamase inhibitory action of tazobactam, which protects piperacillin from enzymatic degradation, allowing it to kill the bacteria.</span></p>",
      "correct_choice_id": 25739,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "OlderNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 33872,
      "choices": [
        {
          "id": 135326,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">No dose adjustment is required</span></span></p>"
        },
        {
          "id": 135327,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add tenofovir 150 mg in the morning</span></span></p>"
        },
        {
          "id": 135328,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add lamivudine 300 mg in the morning</span></span></p>"
        },
        {
          "id": 135329,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Add dolutegravir 50 mg in the morning</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with history of HIV was started on anti-retroviral therapy consisting of lamivudine 300 mg, tenofovir 150 mg and dolutegravir 50 mg once daily at night. Few weeks later, he developed tuberculosis and was started on anti-tubercular drugs. Which of the following dose adjustment may be required in this patient?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(Fmge Jan 2024)</span></span></p>",
      "unique_key": "Q1128747",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683599,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D. Add dolutegravir 50 mg in the morning</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Adjustment of ARV regimen with concomitant ATT:</strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a patient already on 2NRTIs + 1NNRTI (EFV)&ndash;based regimen has to be given 2HRZE + 4HRE&ndash;based ATT for the newly detected TB, same ART regimen can be continued without any modification. </span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a patient already on 2NRTIs + DTG&ndash;based regimen has to be given Rifampicin-based ATT for the newly detected TB, same ART regimen can be continued. However, since co-administered rifampicin reduces bioavailability of DTG, which can be overcome by an additional tablet of DTG 50 mg (at an interval of 12 hours with the regular dose of DTG) till the completion of ATT. Once the ATT is completed, additional tablet of DTG 50 mg should be stopped 2 weeks after stoppage of Rifampicin-containing treatment regimen. </span></span></li>\r\n\t<li style=\"text-align: justify;\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When a patient already on 2NRTIs + PI&ndash;based regimen develops TB, ART regimen has to be modified if 2HREZ + 4HRE&ndash;based ATT is co-administered. </span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If the patient has not taken DTG earlier, patient is shifted to 2 NRTIs + DLG-based regimen with twice daily DTG as discussed in last section</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">If DLG cannot be given due to any reason and boosted PIs need to continued, then rifampicin should be replaced by rifabutin</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective</strong><strong>:</strong><strong> </strong></span></span></p>\r\n\r\n<p style=\"text-align:justify\">&nbsp;</p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients on a dolutegravir-based regimen who start rifampicin-based anti-tubercular therapy, an additional dose of dolutegravir 50 mg should be taken in the morning (12 hours apart from the regular dose) to maintain effective drug levels and manage HIV effectively.</span></span></p>",
      "correct_choice_id": 135329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "FMGE",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6516,
      "choices": [
        {
          "id": 26033,
          "text": "<p><span style=\"font-size:12.0pt;\">Grapefruit juice</span></p>"
        },
        {
          "id": 26034,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcohol</span></p>"
        },
        {
          "id": 26035,
          "text": "<p><span style=\"font-size:12.0pt;\">Benzodiazepine</span></p>"
        },
        {
          "id": 26036,
          "text": "<p><span style=\"font-size:12.0pt;\">SSRI (Selective Serotonin Reuptake Inhibitor)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female patient has been diagnosed with bacterial vaginosis and trichomoniasis. She is prescribed metronidazole as part of her treatment plan. Which of the following should she avoid consuming while on this medication? (NEET PG 2021)</span></p>",
      "unique_key": "Q6166857",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683611,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Alcohol</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Patients taking metronidazole are advised to avoid alcohol consumption. Metronidazole and alcohol can interact to cause a disulfiram-like reaction, leading to symptoms such as flushing, nausea, vomiting, palpitations, and even more severe reactions in some cases. This interaction can occur not only with oral alcohol consumption but also with alcohol contained in mouthwashes and certain medications.</span></li><li><span style=\"font-size:12.0pt;\">Disulfiram is an aversive drug, that inhibits the aldehyde dehydrogenase, leading to accumulation of acetaldehyde in the body, which can lead to symptoms like throbbing headache, flushing, chest tightness, visual disturbances, nausea etc. Hence these symptoms prevent the patient from taking alcohol.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Grapefruit juice</strong>: There is no known significant interaction between grapefruit juice and metronidazole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Benzodiazepine</strong>: While caution may be advised when combining any medications that can have CNS effects, there is not a well-known, specific interaction between benzodiazepines and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. SSRI</strong>: Similar to benzodiazepines, there is not a well-known, specific interaction between SSRIs and metronidazole that would warrant absolute avoidance.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Drugs that can cause disulfiram like reaction include:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C</strong>yclic:&nbsp; <strong>C</strong>efoperazone, <strong>C</strong>hlorpropamide</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>G: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; G</strong>rieseofulvin</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>M: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; M</strong>etronidazole</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>P: &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; P</strong>rocarbazine</span></p>",
      "correct_choice_id": 26034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "RecentNEETPG",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7036,
      "choices": [
        {
          "id": 28112,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia with AV block</span></span></span></p>"
        },
        {
          "id": 28113,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Torsades&rsquo; de pointes</span></span></span></p>"
        },
        {
          "id": 28114,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tachycardia</span></span></span></p>"
        },
        {
          "id": 28115,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular fibrillation</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient was taking metoprolol for hypertension but blood pressure was not controlled. Verapamil was added to the regimen. Which of the following adverse effect is likely to be present with combination? (AIIMS MAY 2020)</span></span></p>",
      "unique_key": "Q1787323",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683618,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A. Bradycardia with AV block</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol is a beta-blocker that is commonly used to hypertension, heart failure, and arrhythmias. It works by slowing down the heart rate and reducing the heart&#39;s demand for oxygen.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Verapamil, on the other hand, is a calcium channel blocker used for similar indications as metoprolol. It reduces the heart rate and has a negative inotropic effect (reduces the force of heart muscle contraction), and can affect the electrical conduction in the heart.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When used together, metoprolol and verapamil can have additive effects on the heart rate and atrioventricular (AV) nodal conduction. This can lead to:</span></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bradycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> An abnormally slow heart rate.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AV block:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> A delay or complete block in the electrical impulse conduction through the AV node of the heart.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Torsades de pointes:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a specific type of ventricular tachycardia that is not typically associated with the combination of metoprolol and verapamil. It is more often related to medications that prolong the QT interval.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Tachycardia:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is an increased heart rate, which is an unlikely side effect of combining metoprolol and verapamil, as both tend to slow the heart rate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ventricular fibrillation:</span></strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> While this is a serious cardiac arrhythmia, it is not a typical side effect of combining metoprolol and verapamil. It&#39;s more commonly associated with ischemic heart disease or other structural heart problems.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The combination of metoprolol and verapamil can lead to significant bradycardia and AV block due to their additive effects on slowing heart rate and AV nodal conduction.</span></span></span></p>",
      "correct_choice_id": 28112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7085,
      "choices": [
        {
          "id": 28308,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nivolumab</span></span></span></p>"
        },
        {
          "id": 28309,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab</span></span></span></p>"
        },
        {
          "id": 28310,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trastuzumab</span></span></span></p>"
        },
        {
          "id": 28311,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ipilimumab</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which among the following drugs is the new FDA approved immune check point inhibitor for carcinoma endometrium?</span></span></span>(INICET MAY 2022)</p>",
      "unique_key": "Q1064135",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683584,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Pembrolizumab</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The new FDA-approved immune checkpoint inhibitor for carcinoma endometrium is Pembrolizumab.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is a monoclonal antibody against PD-1 receptor (Programmed Death Receptor) that can be used for many cancers including endometrial carcinoma. Some of the other cancers where it is useful are:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic urothelial cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Refractory melanoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hodgkin&rsquo;s Lymphoma</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Merkel cell cancer</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chemotherapy Refractory Head and Neck Cancer</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Nivolumab:</strong> is an immune checkpoint inhibitor that acts by inhibiting programmed death receptor - 1 (PD-1) and is used for the treatment of advanced melanoma and relapsed/refractory classical Hodgkin lymphoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Trastuzumab: </strong>is a monoclonal antibody that inhibits the HER2 receptor. It is used in the treatment of HER2-positive breast cancer.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>Ipilimumab:</strong> is a monoclonal antibody that binds to cytotoxic T lymphocyte-associated Protein 4 (CTLA-4) and is approved for the treatment of late-stage melanoma.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\">&nbsp;</p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pembrolizumab is the new FDA-approved immune checkpoint inhibitor for carcinoma endometrium. It works by blocking the PD-1 receptor, enhancing the immune system&#39;s ability to attack cancer cells. It is also used for treating several other cancers, including metastatic urothelial cancer, refractory melanoma, Hodgkin&rsquo;s lymphoma, Merkel cell cancer, and chemotherapy-refractory head and neck cancer.</span></span></span></p>",
      "correct_choice_id": 28309,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual",
        "INICET"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6991,
      "choices": [
        {
          "id": 27932,
          "text": "<p><span style=\"font-size:12.0pt;\">Clearance</span></p>"
        },
        {
          "id": 27933,
          "text": "<p><span style=\"font-size:12.0pt;\">Volume of distribution</span></p>"
        },
        {
          "id": 27934,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasma half life</span></p>"
        },
        {
          "id": 27935,
          "text": "<p><span style=\"font-size:12.0pt;\">Bioavailability</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The loading dose of a drug is governed primarily by? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8793618",
      "question_audio": null,
      "question_video": null,
      "map_id": 32683598,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Volume of distribution</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Loading dose = Volume of Distribution * Target plasma concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Loading dose is the high initial dose of the drug that is initially given to cover the distribution so that the desired action can take place. In other words, when the time to reach a steady-state is long, it may be desirable to administer a loading dose that promptly raises the concentration of drug in plasma to the target concentration.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Clearance</strong>: Clearance is a measure of the body's efficiency in eliminating the drug but does not determine the loading dose. It is more relevant to the maintenance dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Plasma half-life</strong>: The half-life of a drug determines how long it stays in the body but is not directly used to calculate the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Bioavailability</strong>: Bioavailability refers to the fraction of the administered dose that reaches the systemic circulation. While important for understanding the effective dose, it does not govern the calculation of the loading dose.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The loading dose of a drug is primarily governed by its volume of distribution, which helps achieve the desired plasma concentration quickly, especially when the drug has a long half-life.</span></p>",
      "correct_choice_id": 27933,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "AIIMS",
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7165,
      "choices": [
        {
          "id": 28628,
          "text": "<p><span style=\"font-size:12pt;\">Metoprolol</span></p>"
        },
        {
          "id": 28629,
          "text": "<p><span style=\"font-size:12pt;\">Ivabradine</span></p>"
        },
        {
          "id": 28630,
          "text": "<p><span style=\"font-size:12pt;\">Prazosin</span></p>"
        },
        {
          "id": 28631,
          "text": "<p><span style=\"font-size:12pt;\">Frusemide</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A young man sustained a scorpion sting 2 hours ago. On examination, his blood pressure is 154/94 mm Hg; Heart Rate 72 beats/minute, and respiratory rate 32 breaths/minute. He also complains of breathlessness. Which of the following is the preferred drug for management of this patient? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q7926076",
      "question_audio": null,
      "question_video": null,
      "map_id": 33673438,
      "difficulty_level": "beginner",
      "subjects_id": [
        4
      ],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Prazosin</strong></span></p><p><br><span style=\"font-size:12pt;\">Scorpion venom causes release of a large amounts of catecholamines from the adrenals which can lead to hypertension, tachycardia, breathlessness due to pulmonary edema etc. These effects are counteracted by using Prazosin, which is a selective α1 blocker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Metoprolol:&nbsp;</strong>This is a beta-blocker used primarily for managing hypertension, heart rate control, and other cardiovascular conditions. It is not typically used in the management of scorpion stings, as it doesn't directly address the pathophysiological effects of the venom.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Ivabradine:&nbsp;</strong>This drug is used to reduce heart rate in certain conditions such as chronic heart failure and angina. It is not indicated for treating symptoms of scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Frusemide:&nbsp;</strong>This is a diuretic, primarily used to treat conditions like hypertension and edema. It does not have a direct role in managing the effects of a scorpion sting.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Prazosin is the preferred drug for managing the symptoms of a scorpion sting, as it counteracts the effects of catecholamines released due to the venom, providing relief from hypertension and pulmonary edema. Other drugs listed do not directly address the primary pathophysiological effects of a scorpion sting.</span></p>",
      "correct_choice_id": 28630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": "",
      "video_explanation_heading": "",
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "INICET",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}